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Two Approaches for Cell Retention in Perfusion Culture
Systems
Zhaowei Wang
Abstract
A lack of efficient, economical, and reliable cell retention devices has limited the
application of perfusion culture systems in the biopharmaceutical industry. Two types of
cell retention devices were developed in this work for long-term perfusion culture
systems: a modification of an inclined gravity settler and a variation of an ultrasonic
filter. Both bench-top and large-scale tests showed that the gravity settler can effectively
retain viable cells and preferentially remove nonviable cells in perfusion culture systems.
The viable cell retention rate can be maintained well above 90% during long-term
perfusion culture period while the nonviable cell retention rate is 20-30% lower than that
of viable cells. The design of this settler enables its manufacture as a single-use device to
be used in conjunction with disposable bioreactors. An apparatus for measuring the
settling velocities of both the viable and nonviable cells, which is both simple and
inexpensive to use, was developed in order to predict optimal operation parameters of the
gravity settler. The gravity settler was also effective in an algae dewatering process. The
ultrasonic filter has a cell retention capacity 21-fold greater than that of the gravity settler
for the same working surface area. Due to its unique design, this ultrasonic filter can
operate continuously, as opposed to the currently available ultrasonic filters that need onoff intervals for removal of retained cells.
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CHAPTER I
INTRODUCTION

1.1 Overview
Tissue culture technique was first used almost 100 years ago as a way to conduct research
work in developmental biology. Carrel succeeded in keeping tissue alive for over two
months, which demonstrated the possibility of long term in vitro cell culture. The next
milestone was that of Katherine Sanford and co-workers cultured single cells successfully
in 1948.1 Formulated culture medium and the creation of cell lines make cell culture
more realistic and quantitative. In 2007, the sales of biopharmaceuticals in the US were
over $44 billion, a majority of which were produced in animal cells.2

The main culture modes are batch culture, fed-batch culture, and continuous perfusion
culture. Batch culture is the most traditional mode for cell culture. Its major disadvantage
is that only low cell concentration can be reached and cells start to die soon after reaching
the maximum concentration, resulting in low product titer. And much more time is spent
on system shut-down, cleaning, and inoculation compared to continuous cell culture.

1

In fed-batch culture mode, a fraction of the cell suspension is removed from the system at
certain intervals, and an equal amount of fresh medium is added into the system. This
kind of culture is better than batch culture because the time used for shutting down and
cleaning is less. Indeed, the cell loss still cannot be avoided when a portion of culture is
replaced by fresh media. The removal of cells having ability to produce desired product
is undisputedly wasteful

For perfusion culture mode, spent medium is continuously removed from the culture
vessel without losing cells, and an equal amount of fresh medium is added into the
culture vessel. The most important advantage of perfusion culture mode over batch
culture and fed-batch culture is that viable cells are not removed with the spent culture
medium. Cells are retained in the culture vessel to continue to grow and express target
products. For producing the same amount of desired product, the cost for running a
perfusion culture system can be as low as one tenth of fed-batch culture mode.3
Perfusion cultures also can better maintain consistent product quality, and allow steady
state operation and better cell physiology control.4

Although it is apparent for biopharmaceutical companies to prefer perfusion culture to
fed-batch culture mode, the truth is the latter is prevalent for industry. The reason is the
lack of a robust, highly efficient and low cost cell retention device. There are many
technologies currently available for the retention or recycling of cells grown in

2

suspension but all of them have drawbacks limiting their broad application in the
biopharmaceutical industry.

1.2 Specific Aims

The aims of this work are to develop two cell retention devices for perfusion cell culture
systems, which are more robust, efficient and less expensive than currently available
systems.

Specific Aim 1: To develop an inclined gravity settler for long-term perfusion cell
culture.
Gravity settlers are simple to build, are low-cost and easy to operate. The traditional
vertical gravity settler’s volume is too large compared to the working volume of the
bioreactor. Several kinds of inclined settlers have been developed, which offer an
efficient means to selective cell retention. These settlers have an obvious disadvantage:
viable cells are not returned to the bioreactor easily because the cell suspension flow
direction is opposed to the direction of the settled down cells returning back to bioreactor.
The inclined gravity settler we developed overcomes this shortcoming by allowing the
settled cells to move with the fluid in same direction. Meanwhile, the capacity per
volume of the gravity settler is improved significantly compared to previously developed
devices.

3

Specific Aim 1A: Characterization of an inclined gravity settler for cell retention.

An inclined gravity settler with flow co-current to particle movement has been designed.
The performance of the prototype version was characterized in perfusion cultures with
two cell lines, each conducted for over one month. The design was then modified for
industrial-scale use, including changing the material of construction to polycarbonate
which makes it feasible for both disposable and re-usable applications.

Short-term

experimental results demonstrate its efficiency for cell retention at the industrial-scale.

Specific Aim 1B: Develop a method for settling velocity measurement.
The cell retention capacity of the settler is proportional to the cell settling velocity. Cell
settling velocity varies at different growth phases and for different cell lines, which
causes uncertainty of separation efficiency. In order to select operating parameters to
maximize the settler’s viable cell retention capacity for each cell line at its specific
growth stage, a simple method for measuring viable cell settling velocity is needed. This
device was developed and tested with both mammalian cells and standard polystyrene
particles.

Specific Aim 1C: Demonstrate feasibility of a perfusion system with inclined gravity
settler as inoculum source for large-scale culture.
Since the settler can preferentially remove nonviable over viable cells from the perfusion
culture, a perfusion culture using this device is expected to be able to maintain relatively

4

high viability during the perfusion culture period. The feasibility of using this perfusion
culture as an inoculum for a large-scale batch culture was investigated.

Specific Aim 1D: Application of the gravity settler for algae culture dewatering.

Algae culture is a promising alternative for producing biofuel. The major limitation to the
economic viability of this process is the large expense of the dewatering process, i.e.
separation of the cells from the perfusion fluid. Although the algae cells are smaller than
mammalian cells, they have many similar characters. The gravity settler developed for
perfusion mammalian cell culture was evaluated for use with algae cells.

Specific Aim 2: To develop an acoustic-based cell retention device.

Ultrasonic filters utilizing ultrasonic standing waves to retain cell-sized particles have
high capacity per volume. The effect of a porous mesh inserted into the ultrasonic filter
chamber was determined. The commercially available ultrasonic filters need regular
power-off intervals to allow retained cells to leave the filter chamber. An ultrasonic filter
which can be operated continually was developed.

5

Specific Aim 2A: Evaluate performance of cell retention using ultrasonic standing
waves with a porous mesh.

It has been found that porous mesh can enhance particle retention in an ultrasonic filter.
Cell retention performance of this system was investigated and compared to
commercially available acoustic filters.

Specific Aim 2B: Determine the impact of long-term exposure to ultrasonic standing
waves on cell growth and antibody production.

The feasibility of using the ultrasonic filter as a cell bioreactor was studied, with specific
emphasis on the impact of ultrasound stress on cell growth and antibody production
during long term exposure.

Specific Aim 2C: Characterize cell retention using standing ultrasonic waves at an
oblique angle with fluid flow direction.

An acoustic filter with unparallel alignment of acoustic transducer and particle
suspension flow direction was developed and investigated. The middle chamber of the
acoustic filter is unparallel with the transducer and reflector walls. A unique feature of
this acoustic filter is that the carrying fluid flows in the same direction as the movement
of the captured particles, allowing continuous operation of the filter. The retention
efficiency of the device was investigated using mammalian cells and polystyrene.

6

CHAPTER II
BACKGROUND

2.1 Overview
A variety of cell or particle retention devices have been developed.5, 6 Cell retention
devices based on filtration process, such as crossflow microfiltration7-9 and spin filters 1013

, are economical to develop and operate.

The disadvantage is that the membranes

retain nonviable cells and cell debris, which accumulate in the bioreactor and can foul the
sensors within the bioreactor and the retention membrane, resulting in termination of the
perfusion culture process.

Continuous centrifuges14,

15

were developed for

the handling of large-scale cell

separations. It can be operated continuously with small residence time of cells in the
centrifugal chamber. It is being used nowadays for large scale perfusion culture systems.
The main drawback to the system is that it is mechanically complex and might expose
cells to harmful shear stress. The cost is relatively high for each unit too.

7

2.2 Acoustic Filters

The ultrasonic filter has been investigated by many researchers in recent years and has
been successfully applied to perfusion cultures.16-20 It has been described as the most
promising cell retention device for long term perfusion culture.21 This kind of device is
compact and efficient for cell or particle retention. The cell suspension is first pumped
into the lower end of the device. The cells are aggregated by the ultrasonic standing
waves. When the ultrasonic field is on the collected particles mostly kept in the working
chamber of the filter because the hydraulic force which is upward against the moving
down trend of the collected particles. An “off” interval is needed to allow the collected
cell clumps to drop down out of the ultrasonic chamber and back into the bioreactor.
Then the ultrasonic field is turned on and a new cycle of retention is restarted. This “onand-off” cycle operation mode not only increases the complexity of the control system
but also reduces the retention efficiency since the system is not in a steady status at the
beginning of every new cycle. The impact of prolonged exposure to ultrasonic fields on
growth and productivity in a wide variety of cell types is unclear.

It is known that ultrasonic waves at high power level can disrupt cell membranes, and this
feature is used to disrupt cells in the commercially available lab instrument called
sonicator. Other detrimental effects to cells from ultrasonic field exposure are due to
shear stresses and microstreaming associated with oscillations of cavitation bubbles.

8

Conversely, ultrasonic filters for cell retention have been successfully used with no
detectable detrimental effect on cell growth or productivity.22-28 In fact, it has been found
that in some condition, with low power density input, acoustic waves can enhance cell
growth.29, 30 Zhang et al. also found that both proliferation and matrix production of
chondrocytes were enhanced by pulsed low-intensity ultrasound.31, 32 In their experiments,
the proliferation of chondrocytes was increased by 15% over control and the secretion of
type II collagen was increased by 22% over control. It needs to be determined if there is
significant detrimental impact on cell growth and productivity for prolonged exposure to
the ultrasonic standing field at the power lever applied for cell retention using the
ultrasonic filters.

2.3 Gravity Settlers

Gravity settlers are relatively simple to manufacture and are especially suitable for cells
sensitive to shear stress. They not only prevent viable cells from being removed with the
supernatant, but they also preferentially remove nonviable cells from the culture system.
33-36

The avoidance of the gradual accumulation of nonviable cells in the bioreactor is

important since the proteases and glycosidases released by lysed cells may degrade the
secreted antibody.

27, 37, 38

Removal of nonviable cells and debris also helps to reduce

probe fouling resulting in prolonged culture period. Vertical gravity settlers

39

need a

large volume, relative to the bioreactor volume, to separate the cells from the overflow
because of the slow settling velocity of animal cells, resulting in difficulty in large-scale

9

Overflow to
harvest tank
30

Ff+Fh
Net flow direction

G

Underflow returning
to bioreactor
Figure 2.1 Schematic of an upward-flow inclined gravity settler, a single cell sliding down undergoes three
forces, gravity, G; friction, Ff and hydraulic, Fh; the two latter forces oppose cell downward movement.

applications. A horizontal zone has been combined with the vertical settler to increase its
efficiency.23-25, 28

An inclined gravity settler

23-25, 28

results in a sharply reduced settler volume compared to

the vertical gravity settler. When the cell suspension enters the settler from the lower end
of an inclined upward-flow settler, the cells settle to the surface of the lower plate and
then slide down countercurrently to return to the bioreactor (Figure 2.1).28, 39-41 The
downward movement of the settled cells on the lower surface is hindered by the upward
flowing stream, causing an increase in the residence time of the settled cells in the settler.
A long residence time not only has potentially negative impact on cell metabolism but

10

Cell suspension
from bioreactor

55
Net flow direction
Ff

G

Fh

Port II to
Port I to
harvest tank bioreactor

Figure 2.2 A downward-flow inclined gravity settler, a single cell is also under three forces, but the
hydraulic force, Fh, facilitates the downward movement of settled cells.

also allows cells to attach to the lower surface. In order to reduce the chance of cell
attachment, pre-chilling and periodic vibration or bubbling has been used to re-suspend
the cells stalled on the lower surface.42-47

In a downward-flow gravity settler, cell suspension enters at the upper end of the gravity
settler (Figure 2.2). Since the settled cells move downward in the same direction as the
fluid, there is no hindrance from the fluid for the settled cells to return to bioreactor.
Settled cells have nearly the same speed as the fluid and so the cell residence time is
theoretically the same as the fluid residence time. With this design, cells do not
accumulate and no action is needed to re-suspend the stalled cells in the settler. This
makes it more suitable for continuous operation.
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With the use of an effective cell retention devices perfusion cultures can attain much
higher cell densities than that of batch culture mode, but the cell viability is too low to be
used as inoculum for large bioreactors.48 The inoculum viability directly affects the cell
growth in production bioreactors. Kallel et al. showed that the inoculum viability should
be higher than 75%.49-51 In practice the cell viability used as inoculum is around 90%.
Cell viability during perfusion cultures with total cell retention can be improved above
90% by increasing cell bleed rate.52-54 Using this strategy, Heidemann et. al. developed
an innovative method to inoculate large scale cell culture bioreactors in less time. Cells
from high density perfusion bioreactors, in which cells were purged to keep the cell
viability high, were collected and frozen in liquid nitrogen. Then the frozen cells were
thawed and cultured in fed-batch mode to accumulate cells for inoculating a large
production bioreactor. The downside of this approach is the use of cryo-preservation
equipment as well as the loss of viable cells when using the cell bleed strategy.
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CHAPTER III
AN INCLINED GRAVITY CELL SETTLER FOR LONG-TERM
HIGH-DENSITY MAMMALIAN CELL PERFUSION CULTURE

3.1 Introduction

In this chapter we present a modified design of the downward-flow inclined gravity
settler. This design results in greater operational flexibility and improved efficiency in
selective retention of viable compared to nonviable cells. The utility of this design is
demonstrated with two different hybridoma cell lines, hybridoma 9E10 and R73, each
cultured over one month in perfusion systems with the cell settler device.

Due to the slower growth rate and greater sensitivity to growth factor concentrations
compared to bacteria, expansion ratio about 1:10 is required for seeding large-scale
bioreactors, with the seed culture normally started from a 1 mL ampoule.55 Multiple
medium-sized bioreactors are involved in the scale-up process as shown in Figure 3.1.
Normally it would take 3-4 weeks to prepare a seed culture for large cell culture
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bioreactors.56 Apart from the high cost associated with excessive time and labor required
for this process, the risk of contamination is high due to multiple transfers of inoculum.
It is obvious that a smaller inoculum volume and fewer steps are desirable for process

1L

5L

25 L

125 L

Figure 3.1 Conventional seed-train expansion process

optimization in the biopharmaceutical industry. 57, 58

A perfusion system with cell recycle not only results in high productivity it can also be
used to reduce costs for inoculum preparation for large-scale production. The gravity
settler can preferentially remove nonviable cells and cell debris resulting in results in
relatively high cell viability with little loss of viable cells.28, 40 This feature suggests a
possible alternative for seed-train expansion strategy. With both high cell concentration
and viability, the small-scale perfusion culture can be used to provide inoculum for a
large-scale bioreactor. This method can be expected to reduce both time and costs
associated with seed expansion. This feasibility of this process is presented in this chapter
using the R73 hybridoma cell line.

14

3.2 Materials and Methods

3.2.1 Principles of Settler Design and Operation

The working principle of an inclined gravity settler is described by:23, 25

S (v ) = vw( L sin θ + b cosθ )

3.1

where S(v) is the volumetric rate of production of fluid clarified of particles with settling
velocity v, w is the width of the settler, b is the separation distance between the two
inclined surfaces, L is the length of the settler, and θ

is the angle between the

longitudinal axis of the gravity settler and the vertical (Figure 2.1B). The quantity
w( L sin θ + b cosθ ) is the projected area of the inclined gravity settler.

Since normally L>>b,23, 25, 28 Equation 3.1 can be simplified to:

S (v ) = vwL sin θ

3.2

where wL sin θ denotes the projected area of the inclined gravity settler.

Equation 3.2 shows that the processing capacity of an inclined settler is determined by
the product of the projected area of the settler and the cell settling velocity. By knowing
the settling velocity, the projected area needed for processing a given volumetric rate of
cell suspension can be determined.
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With the traditional inclined gravity settler, the only means for changing the projected
area during the culture period, and thus allow changes in the perfusion rate, is to change
the inclination angle.

In previously published work, the upward-flow settlers were

operated with inclination angles of 25 or 30 degrees.23, 25, 28, 40 The upper limit of the
inclination angle is limited by the need to allow the settled cells on the lower plate to
slide down to the outlet port and thus prevent stalling on the lower surface.

3.2.2 Design Details of Downward-Flow Inclined Gravity Settler

In order to increase the flexibility of the inclined gravity settler, we designed a
downward-flow inclined settler with multiple inlets as shown in Figure 3.2. By changing
the position of the inlet the length L is changed and thus the projected area is also
changed proportionally (Equation 3.2), to meet the need of a wide range of processing
flow rates. The settler volume is 45 mL at the farthest inlet position, which is less than
5% of a bioreactor with 1 L working volume. The working volume for this settler is
changeable and is determined by the inlet position. The closer the inlet position is to the
outlet(i.e. the smaller the distance L), the lower the settler working volume, and thus, a
lower corresponding perfusion rate. The upper inlets are connected to the bioreactor via a
fluid distributor. Cell suspension is pumped into the settler via one of the inlets while
valves to the other inlets are closed. The concentrated cell suspension is returned to the
bioreactor via port 1 and the supernatant is pumped to the harvest tank via port 2.
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Multiple inlets

w
L

b

θ

Port 1 to bioreactor
Port 2 to harvest tank

A

B

Figure 3.2 A Schematic of the gravity settler with multiple inlets; B. 3 D illustration of the gravity
settler (L is the length between the selected cell inlet and outlet to bioreactor, w is the width of this
rectangular gravity settler, b is the separation between the upper and lower surfaces of the settler, and θ is
the angle between the longitudinal axis of the gravity settler and the vertical.

The material of construction is borosilicate glass.

The width (w) is 2 cm and the

thickness (b) is 1 cm. There are 12 inlets on the upper surface and two outlets from the
lower surface. The maximum distance between the inlets and port 1 is 20.5 cm. This
length was calculated using Equation 3.2 in order to accommodate a flow rate of 2.4
L/day through the settler, based on a viable cell settling velocity of

2.9 cm/hour

(hybridoma cell line AB2-143.2)23 at an inclination angle of 60o. From our experience,
this settler can be operated at a 60o inclination angle with an occasional shake to loosen
stalled cells. Cell accumulation was virtually eliminated at 55o, which is the angle used
in this work.

3.2.3 Cell Lines and Media
As shown in Table 3.1, two hybridoma cell lines were cultured in the perfusion culture
system. The 9E10 and R73 cells were cultured in BD CellTM Mab serum free medium
17

(BD Biosciences - Advanced Bioprocessing, Sparks, MD).

Both media were

supplemented with 0.1% Pluronic F68 (Sigma, St. Louis, MO) for bioreactor culture. No
other components were added or adjustments made to the media during the culture
process.
Table 3.1 Cell line and culture media
9E10
(CRL-1729)
ATCC
Cell Source
Mouse-Mouse hybridoma
Cell Type
Antibody Isotype IgG1
BD Cell Mab Medium Serum
Culture Medium
Free
Monoclonal antibody against
Cellular
human myc (c-myc) protein
Products:

Cell line

Bioreactor Used

2 L B. Braun stirred bioreactor

R73

Cleveland Clinic Foundation
Mouse-Mouse hybridoma
IgG1
BD Cell Mab Medium Serum
Free
Monoclonal antibody against
rat TcR
2 L B. Braun stirred bioreactor

3.2.4 Analytical Methods
Cell density and viability were evaluated using trypan blue exclusion method with a
hemocytometer. Concentrations of antibody IGg1 in culture supernatants were measured
using a standard ELISA kit (Alpha Diagnostic International, San Antonio, TX) see
appendix A.

3.2.5 Bioreactor System and Culture Protocol

The perfusion culture system is shown in Figure 3.3. A 2-L B.Braun stirred bioreactor (B.
Braun biotech, Allentown, PA) with 1 L working volume was used for culturing 9E10
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and R73 cells. A four-gas control module was applied to maintain the DO at 50%. The
set point of pH was 7.2 but it fluctuated between 6.8 and 7.2 since no base or acid was
supplied during the culture. A 1-L B.Braun stirred bioreactor with 1 L working volume
was used for the inoculation test with R73 cells.

Cells were cultured in T-flasks in a humidified 5% carbon dioxide incubator at 37oC.

Recirculation stream

F

Cell suspension stream

Sampling port

XR

V

Xo
Sampling port

Fresh medium

Stirred bioreactor

Gravity settler

Harvest tank

Figure 3.3 Schematic of the perfusion culture bioreactor system

Cells in exponential growth phase were inoculated in the stirred bioreactor. Perfusion
culture was started at the stationary growth phase of the bioreactor batch culture.
Samples were taken from the bioreactor and the line to the harvest vessel (port 2). The
recirculation rate was maintained constant at 0.8 L/day, while the perfusion flow rate was
varied from 0.8 to 1.6 L/day.
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3.2.6 Inoculation Test Protocol

The viable cell concentration reached 49x106 cells/mL after the perfusion rate was
doubled gradually over a period of 6.4 days (see Figure 3.4). At this point, a 4 mL cell
suspension was withdrawn from the perfusion bioreactor and used to inoculate the 1-L
bioreactor for a batch culture as shown in Figure 3.5, resulting in a 2x105 viable cells/mL
initial cell concentration at a 1:250 expansion rate. A control batch culture was conducted
with inoculum from T-flasks with a 1:5 expansion ratio, resulting in an initial cell
concentration of 2x105 viable cells/mL.

3.2.7 Calculations

The cell retention rate, R, is defined as:

R=

XR − XO
× 100 %
XR

3.3

where XR is the cell concentration in the bioreactor; XO is the cell concentration in
the overflow stream that exits the gravity settler via port 2 to the harvest tank.

Antibody volumetric productivity p V is the amount of the antibody produced per day per
reactor working volume, given by:
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Figure 3.4 R73 cell culture results. A. cell growth curve B. cell retention rate C. viable cell concentration vs. antibody concentration D. specific cell growth
rates vs. specific antibody production rates
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4mL

1L

1L

Figure 3.5 Schematic of using the perfusion culture bioreactor to inoculate a batch culture bioreactor

pV =

( PMax − PInitial )
t Total

(batch culture )

3.4

(perfusion culture)

3.5

and
pV = P +

∆P
∆t

where PMax is the maximum antibody concentration achieved during the batch culture;
PInitial is antibody concentration in the inoculum; tTotal is the total time taken for the batch
culture to reach the maximum antibody concentration (assuming that the batch culture is
conducted ideally, ie. the batch culture terminated as soon as the maximum antibody titer
is achieved.); P is the average antibody concentration of two consecutive samples; ∆t is
the time interval between two consecutive samples; ∆P is the difference in antibody
concentration of two consecutive samples.
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Specific rates of cell growth and antibody production are calculated using the following
equations, which were discribed previously: 59 22, 60

µ=

X T (t )
XT
X 1
F
µ app = T  Ln
+ (1 − Rv ) 
Xv
X v  ∆t
X T (t −1)
V 

∆P  1
F
qP =  P +

∆t  X v
V

3.6

3.7

where µ is the specific rate of cell growth (h-1); qp is the specific rate of antibody
production (pg/viable cell/h); µapp is apparent cell specific growth rate (h-1); F is
perfusion flow rate (L h-1); V is the working volume of bioreactor; The perfusion rate in
day-1 is defined as F/V; X v and X T are viable and total cell concentrations (cells/mL),
respectively; X T
and X T ( t ) are total cell concentrations at time t-∆t and time t; Rv is
(t − ∆t )
viable cell retention rate; and X T and X v are the average cell concentration of two
consecutive samples; ((1 − Rv )F / V ) is the viable cell bleed rate. Equation 3.6 shows that
in steady-state during perfusion culture, the apparent specific growth rate is equal to the
viable cell bleed rate.

3.3 Results and Discussions

3.3.1 9E10 Perfusion Culture

Figure 3.6 shows the perfusion culture results with 9E10 cells. The maximum viable cell
concentration reached during the perfusion culture period is 10-fold that achieved at day
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3.5 in batch culture period (Figure 3.6A). The difference in retention rates between
viable and nonviable cells is 20% on average (Figure 3.6B). When the perfusion rate was
doubled from 0.8 day-1 to 1.6 day-1 the cell concentration oscillated with no sustained
change and did not increase accordingly (Figure 3.6A). At the 1.6 day-1 perfusion rate
and measured retention rate, the cell bleed rate is 0.16 day-1; at these conditions the
perfusion culture is unlikely to be limited by nutrient availability.61

However, at 1.6

day-1 the average viable cell retention rate decreased to 90% (Figure 3.6 B). Therefore
the expected increase in cell numbers due to increased perfusion rate was partially offset
by the lower cell retention rate of the 9E10 cells. This phenomenon is in good agreement
with results reported by Dalm et. al.49 The perfusion culture was terminated earlier than
planned due to malfunction of the pH probe.

The gravity settler was designed for a maximum flow rate of 2.4 L/day based on a 2.9
cm/hour settling velocity of viable cells. However, the settling velocity of viable 9E10
cells is less than 2.9 cm/hour (Table 3.2). According to Equation 2, the length of the
gravity settler needed for achieving 100% cell retention of the 9E10 cells at these
conditions is 22.9 cm, which is longer than the 20.5 cm device used here. This finding
supports the necessity of using a long device with flexible inlet positions for maximizing
retention of different cell lines with different settling velocities.
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Figure 3.6 9E10 cell culture results. A. cell growth curve B. cell retention rate C. viable cell concentration vs. antibody concentration D. specific cell
growth rates vs. specific antibody production rates
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Table 3.2. Cell settling velocity comparison
Cell Line
9E10

Viability

Viability

Settling Velocity (cm/h)

97%

Viable
Viable
Nonviable
Viable
Viable
Nonviable

2.6
1.8
0.9
1.8
0.9
0.6

65%
95%

R73

65%

During most of the batch culture and perfusion culture with 0.8 day-1 perfusion rate, the
antibody concentration is almost linearly proportional to viable cell concentration (Figure
3.6C). When the perfusion rate was doubled the antibody concentration decreased by
50%. However, the specific antibody productivity is similar for the two periods (Figure
3.6D). The specific cell growth rate fluctuates dramatically during the culture. Although
it has been broadly reported that specific antibody production rate drops when the
specific growth rate increases, 59, 60, 62, 63 this relationship is not clearly demonstrated here.
In general, the antibody production for this cell line is growth associated, i.e., the higher
the cell concentration, the higher the antibody titer (Figure 3.6C). Therefore, with this
cell line, the same result as that concluded by Hiller et. al.64 is true, i.e., a higher antibody
volumetric productivity can be reached at higher perfusion rate as long as cell retention is
maximized.

3.3.2 R73 Perfusion Culture

The maximum viable R73 cell concentration during perfusion culture at 0.8 day-1 is about
8-fold of that achieved during the batch culture (Figure 3.4A). Compared to results with
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9E10 cell line, the viable cell retention rate is much lower with the R73 cells, with an
average of 88% throughout the perfusion culture period (Table 3.4, Figure 3.4B). The
lower retention rate is a direct result of the significantly lower settling velocity of the R73
cells, measured at 1.8 cm/hour (Table 3.2). The settler length needed for 1.6 day-1
perfusion rate with this settling velocity is 33.3 cm (from Equation 3.2), which is larger
than the maximum length of device used here. Notwithstanding this calculation, at many
points the cell retention rate over 95% was achieved even with 1.6 day-1 perfusion rate.
This result is attributed to the observation that the initial speed of the fluid as it enters the
device is perpendicular to the settling surface, which results in a higher actual cell settling
velocity. As a result, this inclined gravity can handle perfusion rates somewhat higher
than the theoretical calculation based on settling velocity.
Table 3.3. Average cell retention rate comparison between the two cell lines throughout
the perfusion culture period
Hybridoma 9E10
Average viable cell
94±4
retention rate (%)
Average nonviable cell
72±7
retention rate (%)

Hybridoma R73
88±9
75±9

As with the 9E10 cell line, when the perfusion rate was doubled in one step from 0.8 day1

to 1.6 day-1 the viable cell concentration did not increase accordingly. But when the

perfusion rate was increased in seven steps from 0.8 day-1 to 1.6 day-1, the viable cell
concentration almost doubled. At the first three steps of perfusion rate increase, the cell
retention rates are higher than most of those achieved during perfusion culture with 0.8
day-1 perfusion rate. As the perfusion rate gradually increases, the cell viability also
increases as shown in Figure 3.4A, which most likely increases the settling velocity, as
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Figure 3.7 R73 cell antibody volumetric productivity comparison between batch culture and steady-states
of perfusion culture n is the data point numbers in the steady status of perfusion culture

period, error bars denote SD.
shown in Table 3.2. The combination of these two effects results in lower equivalent
bleed rate and thus higher viable cell concentration.49 This result suggests that a gradual
increase in perfusion rate is more effective in achieving high cell density than one step
increase. Both the antibody titer and the antibody volumetric productivity were
significantly improved, 7-fold (Figure 3.6C) and 40-fold (Figure 3.7), respectively,
during the steady state of culture period with 0.8 day-1 perfusion rate (first phase)
compared to the batch culture.
As shown in Figure 3.4C, the antibody concentration is roughly proportional to the
viable cell concentration during batch culture and perfusion culture with 0.8 day-1
perfusion rate (first phase), similar to the results with the 9E10 cells. However, in
contrast with the 9E10 cells, both the R73 antibody concentration and specific antibody
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production rate decreased sharply right after the perfusion rate doubled from 0.8 day-1 to
1.6 day-1. Furthermore, the specific antibody production rate did not recover even after
the perfusion rate was changed from 1.6 day-1 to 0.8 day-1. There are several possible
explanations for this loss in productivity. Ozturk et al. reported the antibody productivity
significantly decreased for a hybridoma cell line cultured in 1.25% serum media
compared to that cultured in 20% serum media. It took four weeks of culture in 20%
serum media to recover the antibody productivity.65 In our experiments, the higher

perfusion rate may have diluted some factors associated with antibody production which
could not be accumulated quickly enough during the short periods of low perfusion rate.
Secondly, it has been shown that an increase in perfusion rate, and thus the bleed rate,
increases the accumulation rate of a nonproducing subpopulation of cells in the culture.66
In fact, it has been suggested that the ideal perfusion rate should be around 1 day-1.67, 68
Higher perfusion rates more than 1 day-1 were used here to investigate the capacity of the
settler with a volume-limited bioreactor.

According to Equation 3.2, a downward-flow settler at 55o can process 64 - 94% more
cell suspension compared to an upward-flow settler with the same dimensions at 30 25o.respectively. With co-current movement of the settled cells and the supernatant,
there is insignificant cell accumulation in the gravity settler, and thus there is no need for
methods to facilitate removal of the accumulated cells. This results in a much simplified
operation. The adjustable inlet position permits operation of the device over a wide range
of perfusion rates and with cell lines with significant variation in settling time. A
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minimized settler working volume is advantageous for reducing the time of exposure of
the cells to the unfavorable environment of the settler.

3.3.3 Residence Time Comparison

In a traditional upward-flow gravity settler, the hindrance of hydraulic force and friction
force from the settler surface (Figure 2.1 A) makes the settled cells prone to stall on the
lower surface. The average residence time of settled cells is 60% longer than that of the
fluid, and over 10% of the cells were shown to have stalled in the settler even with the
assistance of fluid pre-chilling and vibration.28

In the downward-flow gravity settler presented here, settled cells move in the same
direction as the cell supernatant stream. Therefore the movement of settled cells are
facilitated rather than hindered by the fluid movement (Figure 2.1B). During the steady
states of the perfusion cultures, for all cell lines tested, no cell accumulation on the lower
surface was observed. The settled cells formed a thin layer and moved downward along
with the fluid in the settler.

At day 44.3 (Figure 3.4A) of the perfusion culture of R73 cell line, cell concentration in
the bioreactor was 3.7x107 cells/mL. The flows into the gravity settler and out via port 1
were temporarily shut off and the cell suspension was completely collected via port 2
after vigorous shaking of the gravity settler. The cell concentration in the gravity settler
was measured at 3.9x107 cells/mL, which is negligible difference from the stream
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entering the gravity settler. This indicates that cell stalling in the downward-flow gravity
settler was negligible and that the settled cells move at almost the same rate as the cell
suspension. No pre-chilling, periodic vibration, or bubbling was needed to facilitate the
cell removal. Only an occasional shake of the settler was performed once every one to
two days to help remove cells retained in some dead corners.

3.3.4 Inoculation Test

Cell growth curves using the inoculum from the perfusion systems and T-flasks as
control are shown in Figure 3.8. The maximum cell concentration is similar for the two
cultures but the lag phase of the culture with inoculum from perfusion culture is longer
than that of culture with inoculum from T-flask culture. This can be explained by the
initially lower growth factor concentrations that occurred in the batch reactor when using
the smaller inoculum volume (4 mL from perfusion, compared to 200 mL from T-flask).
With a smaller inoculum volume, more time is needed to accumulate enough growth
factors, leading to elongation of the lag phase. The influence of conditioned medium on
lag time was demonstrated by Ozturk et al., who reported that the maximum cell
concentration was reached about 24 hours earlier for culture with addition of conditioned
media to 1.25% serum media compared to the unconditioned media with same serum
concentration69. They also showed that the maximum viable cell concentrations reached
in the two cultures were similar.
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Figure 3.8 Cell growth curve for batch culture with inoculum both from T-flasks and perfusion culture
bioreactor

The duration of the stationary phase of the culture with the perfusion inoculum is shorter
than that of the culture with the T-flask inoculum. This will not be a problem for semicontinuous or continuous production culture since medium replacement begins before
cell viability drops below 90%.

The cell seed from the T-flask was obtained when the viable cell concentrations reached
about 1x106 cells/mL, resulting in a 1:5 expansion, as is commonly used. However, the
viable cell concentration in bioreactor batch culture can reach as high as

3.5x106

cells/mL as shown in Figure 3.8, suggesting that the expansion ratio with inoculum from
a batch culture reactor can be increased up to 1:18.

This improvement in maximum

viable cell concentration, compared to values traditionally obtained, can be attributed to
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the optimized medium formulations and improvements in cell lines.

A potential 1:18

expansion ratio from batch culture is still significantly surpassed by the 1:250 ratio
achieved with inoculum from the perfusion culture bioreactor, while the latter has
potential to be further improved with additional optimization studies.

As shown in Figure 3.9 the maximum antibody concentration in the batch culture with
the perfusion inoculum (18.7 mg/mL at 144 hour) was similar to that obtained with the Tflask inoculum (17.8 mg/mL at 117 hour). It has been shown that the antibody production
linearly relates to the integral of viable cell concentration regardless of initial inoculum
size and serum concentration.69, 70

So it is not surprising to see comparable antibody

production based on the similar maximum viable cell concentration as shown in Figure
3.8.
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Figure 3.9 Antibody production comparison between batch cultures with inoculum both from T-flasks
and perfusion culture bioreactor
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The time difference for reaching the maximum antibody concentration (27 hours) is
similar to the time difference (29 hours) of reaching maximum cell concentration
between these two cultures.

When batch culture is used for production, the cell

suspension should be collected around the time when maximum antibody concentration is
reached. We can define a collection window as shown in the Figure 3.9, in which the
antibody concentration is above 16 mg/mL. The length of the collection window is about
20 hours with the T-flask inoculum and about 10 hours with the perfusion inoculum. This
difference in the collection window should not be a problem with frequent sampling near
the end of the culture.

Although the specific antibody production rate decreased significantly for cells grown in
the perfusion culture with 1.6 day-1 perfusion rate compared to those in the batch culture
as shown in Figure 3.4D, apparently the specific antibody production rate fully recovered
when the cells from the perfusion culture were inoculated into the batch culture. This is in
good agreement with the finding of Morrill,
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who demonstrated that the decrease of

antibody productivity in high density culture can be reversed when they are transferred
into low cell density culture.
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CHAPTER IV
A SIMPLE APPARATUS FOR MEASURING CELL SETTLING
VELOCITY

4.1 Introduction

Gravity settlers have been successfully applied as cell retention devices in perfusion cell
cultures from the bench-top to large-scale industrial applications.23, 25, 26, 39, 40, 72-76

The

capacity of an inclined gravity settler to clarify cell suspension is described in equation:

S (v) = v ⋅ w (Lsin θ + bcosθ )

4.1

where S(v) is the volumetric flow rate of fluid clarified of particles with sedimentation
velocity v; w(Lsinθ+bcosθ) is the projection area of an inclined gravity settler; w is the
settler width, b is the separation between the two inclined surfaces, L is the length of the
settler, and θ is the angle of inclination of the settler from the vertical. Batt et al. and
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Davis et al. have successfully predicted the cell retention efficiency of gravity settlers
based on theoretically calculated cell settling velocities. 23, 25

The accurate determination of the viable cell sedimentation velocity is critical for
controlling the operation of the gravity settler to maximize viable cell recycling and thus
viable cell concentration in the bioreactor. During long-term perfusion culture, the cell
suspension is a mixture of viable and nonviable cells, and the nonviable cells have
settling velocities that are less than that of the viable cells. 23, 74

Viable cell settling velocity can vary significantly among mammalian cell lines; for
instance, the settling velocity of hybridoma cell line AB2-143.2 and CHO cell line M1-59
are 2.9 cm/h and 1.45 cm/h, respectively.23, 74 This two-fold difference demonstrates the
necessity of measuring this parameter for every new cell line to be used in a gravity
settler/perfusion system in order to properly select the gravity settler with appropriate
capacity.

Moreover, the settling velocity of viable cells may change substantially during the course
of a long-term perfusion culture due to changes in cell size.59, 62, 77, 78 It is thus important
to measure the distinct settling velocity of the viable and nonviable cell populations
periodically during a long-term perfusion culture in order to optimize the operation of the
gravity settler in real-time.
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The measurement of erythrocyte sedimentation rate (ESR) has been widely used for over
50 years as a simple, standardized medical screening test.79-84

Although many

modifications have been made to speed-up the procedure,85-87 the basic operational
principle is the same. A sample of blood is placed in a narrow tube (Westergren Tube)
and after a period of time a visible interface forms between the clarified plasma and the
red blood cells. By reading the scale at the interface after a defined period of time the
sedimentation can be determined. This method assumes the red blood cells have uniform
size and settling velocity; therefore the movement of the red blood cell population is
taken as the distance that the cells at the top of the tube can move in certain time. This
method is not directly applicable to mammalian cell culture, since there is not a clear
color difference between the cells and the clarified supernatant. For the same reason, the
method used to determine plant cell settling velocity is not practical for animal cell
culture.88 Even if there is a clearly identifiable interface, only the settling velocity of the
smallest nonviable cells can be determined in this manner. This measurement is much
less important than that of the viable cells for optimizing the gravity settler operation.

Particle image velocimetry (PIV) has been used primarily for directly measuring the
settling velocity of individual particles.89 Despite the complexity of this process, it
cannot distinguish between viable and nonviable cell settling velocity. Another method,
the “Owen Tube”, is a 1-L column used for determining the settling velocity of
suspended particulate matter in natural body water.90-92 Periodic samples are removed
from the bottom of the Owen Tube and the dry weight measurement is used to determine
the settling velocity. This method is not accurate for small sample amounts, the presence
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of cell debris would contribute to measurement error, and the process can not distinguish
the viability of the cells.

Stokes’ Law can be used to theoretically calculate the settling velocity of particles in
fluid when the Reynold’s number is less than 0.2, given by:

v=

(

gd 2p ρ p − ρ

)

4.2

18 µ

where dp = particle diameter; µ=fluid viscosity; ρp= density of solid particle; ρ= density
of carrying fluid; g is acceleration due to gravity. The particle diameter is normally
determined by means of a Particle Size Analyzer (Particle Data Inc.) or Coulter
Multisizer (Beckman Coulter, Fullerton, CA). The particle density is measured using
neutral buoyancy measurement or density gradient partitioning methods.

A glass

capillary viscometer can be used to determine the fluid viscosity. The fluid density is
easily determined from weight and volume measurements. Using this procedure, the
settling velocity of viable and nonviable hybridoma and CHO cells have been
determined.23, 74 This method is not practical for routine measurements during long-term
perfusion culture since multiple measurements are needed for a single settling velocity
determination, which is time-consuming and increases the potential for measurement
error.

We have developed a simple, inexpensive, and rapid method for measuring settling
velocity of both viable and nonviable cells in a mixed population, based on a
modification of the Westergren Tube. The accuracy of this method is demonstrated using
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polystyrene particles with known physical properties.

The method is then used to

measure the settling velocity of three different hybridoma cell lines.

4.2 Materials and Methods

4.2.1 Settling Column

A schematic of the settling device is shown in Figure 4.1. The device consists of a
rectangular settling column made of 2.4 mm glass plate. The column has an internal
width of 1.4 cm an internal length of 2.0 cm, and a height of 11.5 cm. There is a 0.6 mm
wide slot in the narrow side of the column, at a distance of 4 cm from the bottom. At the
same height as the slot is a 0.6 mm wide and 0.5 mm deep groove on the other three sides
of glasses. The groove is filled with silicone glue (General Electric). The edge of the
plate glass at the slot is also coated with the silicone glue. A shutter is made of 0.5 mm
thick and 4.5 cm long stainless steel plate which is slightly wider than the width of the
slot. The groove in the glass works as a track to guide the shutter through the slot. The
function of the cured silicone glue is to help seal the contact between the shutter and glass
surface. When conducting the settling velocity measurement, high vacuum grease was
also applied to the interface between the glass plate and the shutter to help seal the
contacts. When the shutter is pushed into the column, the lower part of the column can be
totally closed. The settling column is exactly perpendicular to the supporting 7 cm x 7
cm glass plate, to which it is glued. The device should be located on a leveled horizontal
surface so the settling column is strictly vertical.
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B

A

Figure 4.1 Schematic of the settling column. (A) Side view. (B) 3-D view.

4.2.2 Standard Particles

Monodisperse standard polystyrene particles (Sigma, St. Louis, MO) with 15±0.2 um
diameter (mean ± standard deviation) and 1.05 g/cm3 density (both values reported by the
manufacturer) were used to verify the reliability of the device. The particles were
suspended in DI water supplemented with 0.1% Triton X-100 (Sigma, St. Louis, MO),
which helps prevent the particles from aggregating.

The viscosity of the solution

(without the particles) at 28 oC is 0.0084 poise, as measured using a size 25 glass
capillary viscometer (Cannon Instrument Co. State College, PA). The density of the fluid
is 0.996 g/cm3. The concentration of the particle suspension is 1.8 x 105 particles/mL,
resulting in 0.03% volume fraction. All the particle settling velocity measurements were
conducted in a 28 oC incubator.
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4.2.3 Cell Lines and Cell Culture

Three hybridoma cell lines, HB-159 (ATCC), 9E10 (ATCC) and R73 (Cleveland Clinic
Foundation, Cleveland, OH), were tested with the settling column. All cells were cultured
with BD CellTM Mab serum free medium (BD Diagnostic Systems, Sparks, MD) and
maintained in 250mL T-flasks in a 37oC incubator with 5% carbon dioxide. Cell settling
velocity measurements were conducted with cells in the exponential growth phase, in the
second day after inoculation; and with cells in death phase, in the fifth day after
inoculation. The nonviable cell settling velocity was measured only when the population
viability was lower than 70% in order to obtain enough nonviable cells to be counted
accurately using a hemacytometer. The cell suspension in the T-flask was pipeted several
times to disassociate any cell clusters. The cell suspension was not diluted before being
introduced into the column, at concentrations of 1 – 2 x106 cells per mL. All cell settling
velocity measurements were conducted in the 37 oC incubator. Cell size distribution
measurements of HB-159 were conducted with cells cultured 2, 6, 9, 13 and 17 days after
inoculation.

4.2.4 Particles and Cell Counting

The polystyrene particles were counted using a Z2 Coulter Counter (Beckman Coulter,
Fullerton, CA) equipped with a 70 um ampoule aperture tube. The lower threshold was
set at 14 um and higher threshold was 16 um. The Coulter Counter was also used to
determine the cell size distribution of the HB-159 cells. The cell concentration and
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Figure 4. 2 Protocol of particle settling velocity measurement using the cell settling
column. A. Fill the column with well mixed monodisperse particle suspension with
known concentration. B. Particles moved downwardly h’ distance in one hour. C.
Separate the column in two parts by pushing in the shutter to stop particles from moving
into the lower part of the column. D. Remove the particle suspension above the shutter.
E. Re-suspend the settled particles from the bottom of the column and well mix, then
sample and measure particle concentration.

viability were measured using a hemacytometer and trypan blue exclusion method. More
than 1000 viable cells were counted for each sample.

4.2.5 Settling velocity Measurement Procedure and Analysis

A sample containing 28 mL of the well-mixed monodisperse particle suspension is added
to the settling column (Figure 4.2A) with the shutter open. Assuming uniform particle
density and diameter, the particles settle down at the same rate, traveling a distance h'
over the settling time period t (Figure 4.2B). The particle settling velocity is given by:

v=

h'
t

4.3

The volume of the column vacated by the particles is given by:
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V ' = h'⋅s

4.4

where s is the cross section area of the settling column. Similarly, the volume below the
shutter, V, and the volume between the shutter and the interface, V", are given by:

V = h⋅s

4 .5 ( a )

V ' ' = h' '⋅s

4 .5 (b )

At time=t, the shutter is closed (Figure 4.2C). The particle suspension above the shutter
is first removed (Figure 4.2D). The settled particles on the bottom of the column are then
resuspended and thoroughly mixed with the remaining particle suspension below the
shutter. Mass is conserved between time=0 and time= t, yielding:

4.6

X 1 (V '+V ' '+V ) = X 1V ' '+ X 2V

Where X1 is the particle concentration in the initial suspension added to the column;
V is the volume of the column below the shutter; and X2 is the particle concentration after
re-suspending and mixing the settled particles in the space below the shutter (Figure
4.2E).

Combining Equations 3,4, 5(a), and 6 yields:

v=

h( X 2 − X 1 )
tX 1

4.7
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The distance h is fixed by the device design and X1 is known from the sample preparation.
The experiment is conducted for a known amount of time t, such that the particle
interface remains above the shutter position during the time t.

Therefore the only

measurement needed is that of the particle concentration in the lower volume.

The same experimental and analytical procedures were used for the calculation of the
settling velocities of the viable and nonviable cells. Samples were counted for both
viable and nonviable cell numbers and Equation7 applied to each population.

4.3 Results and Discussion

4.3.1 Theoretical Calculation of the Particle Settling Velocity

The settling velocity of 15 um polystyrene particles at 28oC was calculated using
Equation 1 and the data in the Methods section to be 2.81 cm/h.

To confirm the

applicability of Stokes’ law to this system, the Reynolds number was calculated using:

Re = ρ p d p v / µ

4.8

The calculated Re number is 0.0014, indicating that the settling velocity is indeed
governed by Stokes’ law.
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The corrected settling velocity can be calculated taking into account particle
concentration and wall effects by means of:93

ν ts = ν (1 - c)n /(1 + 2.1β )

4.9

where vts is the corrected settling velocity, v is the settling velocity of a single particle
calculated from Stokes’ law; c is the volume fraction of the particles in the fluid; n is a
function of Reynolds number, equal to 4.65 when Reynolds number is less than 0.3; and
β is the ratio of particle diameter to vessel diameter.

The hydraulic diameter is

commonly used to calculate the equivalent diameter when handling flow in noncircular
channels, defined as:

dh =

4A
U

4.10

where A is the area of the cross-section of the rectangular channel and U is the wetted
perimeter of the cross-section. The hydraulic diameter of the settling column used here is
1.47 cm.

The corrected theoretical settling velocity for the polystyrene particles, calculated using
Equation 9 with concentration of 1.8x105 particles/mL (volume fraction of 0.03%), is
2.80 cm/h. The difference between the calculated value using Stokes’ law and the
corrected one is less than 0.4%, indicating that the effects of concentration and the wall
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are negligible.

The concentration effect on settling velocity increases sharply at

concentrations greater than 1x107 particles/mL (Figure 4.3A). Neglecting the
concentration effect at the expected cell concentration during perfusion culture, 5x107
cells/mL, causes a 30% error from the actual settling velocity. The large effect of cell
concentration on settling velocity demonstrates the advantage of a direct measurement of
this property using the settling column, rather than a theoretical calculation using Stokes’
law. As shown in Figure 4.3B, the wall effect is still negligible even at half the hydraulic
diameter of the current settling column prototype. This result indicates that the minimum
cell suspension volume needed for use in the settling column can be reduced to less than
10 mL with no material impact on the accuracy of the measurement.

4.3.2 Standard Polystyrene Particle Settling Velocity Measurement
e settling velocity of the polystyrene particles, measured using the settling column, is
2.70±0.08 cm/h (mean ± standard deviation; Figure 4.4). This value is 3.6% smaller than
the theoretical value, corrected for wall and concentration effects. This small deviation is
most likely caused by particle inertial effects, which are difficult to predict.89, 94-98 It is
almost impossible to totally avoid swirling or convective motion of the particle
suspension. Particle inertia influences the settling velocity at both the micro-scale and
macro-scale. In order to minimize the inertial effect by avoiding convection caused by a
temperature difference, the settling column and particle suspension should be at the same
temperature before the suspension is added to the column. Convection can also be
reduced by the slow addition of the suspension to the column.
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Figure 4.3 Calculation of concentration effect and wall effect based on polystyrene
particles with 15 um diameter. (A) Concentration effect. (B) Wall effect.
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Calculated settling velocity

Measured using settling column

Figure 4.4 Comparison of the settling velocities of 15 um polystyrene particles,
calculated using Stokes’ law (corrected for wall and concentration effect ) and the
measurements described in the Methods section (left) and measured using the settling
column (right). The error bar indicates the standard deviation and n is the number of
repetitions. P=0.09

4.3.3 Hybridoma Cell Settling Velocity Measurements

The size distributions of the HB-159 hybridoma cell line at different lengths of time in
culture are shown in Figure 4.5. Two peaks are evident, at diameters of 10 µm for
cultures aged 13 and 17 days and at diameters of 14.5 µm for cultures aged 2 days. The
percentage of cells with the lower diameter increased with decreasing viability while the
percentage of cells at the higher diameter decreased with decreasing viability. The first
peak at 10 µm most likely denotes nonviable cell population and the second peak at 14.5
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µm denotes the viable cell population. These results are in agreement with results
reported by Searles et al. in which the mean size of nonviable cells is significantly
smaller than that of the viable cells.74 Not only are nonviable cells smaller than viable
cells, but also the nonviable cells decrease in diameter as the population viability
decreases.74 It has also been reported that viable cell diameter increases over 20% when
the cells progress from lag phase to exponential phase.99, 100

Table 4.1 shows the settling velocities of three hybridoma cell lines measured using the
settling column along with settling velocities of two cell lines reported in the literature. 23,
74

The variation in settling velocities of the three hybridoma cell lines is significant, with a

Table 4.1 Comparison of cell settling velocities. The settling velocities of the HB-159,
R73 and 9E10 cell lines were achieved using the settling column. The results for the
hybridoma AB2-143.2 and CHO M1-59 cell lines were reported in the literature.23, 28
Settling Velocity (cm/h)
Cell Line
Viability (%)
Viable
Nonviable
94
3.5
N/A
Hybridoma HB-159
64
2.8
1.7
Hybridoma R73
Hybridoma 9E10

96

1.8

N/A

65

0.9

0.6

97

2.6

N/A

65

1.8

0.9

Hybridoma
AB2-143.2
N/A
2.9
1.1
(Batt et al. 1990)23
CHO M1-59 (Searles et
N/A
1.4
0.86
al. 1994)28
two-fold variation between the HB-159 and the R73. These measurements are similar to

values reported for a hybridoma cell line and a CHO cell line, obtained using Stokes’
law.23, 74 The two-fold variation in settling velocities indicates that the cell line with the
lower velocity will need a gravity settler that is double in size to achieve the same cell

49

retention capacity as that of the faster-settling cell line. This confirms the necessity of
measuring the settling velocity before selecting the gravity settler and starting the
perfusion culture.

The settling velocities of the nonviable cells are 30-50% lower than the corresponding
viable settling velocity (Table 4.1). This difference is the basis of preferential removal of
nonviable cells using gravity settler in perfusion culture bioreactors.

Table 4.1 also shows that even for the same cell line, the viable cell settling velocity
decreases significantly, up to 50%, when viability of the cell suspension decreases from

0.9

Day 2, 98% Viable
Day 13, 32% Viable

0.8

Day 6, 56% Viable
Day 17, 26% Viable

Day 9, 48% Viable

Percentage (%)

0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
5

7

9

11

13

15

17

19

Diameter (u m)
Figure 4.5 Size distribution histograms of HB-159 hybridoma cells cultured in 250 ml
T-flask. Percentage is based on cell number
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97% to 65%. Since a lowered viability is a normal outcome during long-term perfusion
culture, this result indicates that the minimum capacity of the gravity settler would need
to be doubled to maintain the cell retention efficiency throughout the culture period.
Otherwise, loss of viable cells would likely occur. Therefore it is necessary to measure
the cell settling velocity periodically during the perfusion culture especially when the cell
viability drops significantly.101

Since each cell population has a size distribution as indicated in Figure 4.5, it is expected
that each population would also have a distribution of settling velocities. The settling
velocity reported here represents a number-average value for each population, since it is
determined from a count of cell number. One could determine an average settling
velocity for each subpopulation defined by a size criterion using a particle counter to
quantify both total cell number and size distribution. However, in practical application, a
population-average settling velocity is sufficient for optimizing operation of an inclined
gravity settler.23, 25

4.3.3.1 Analysis of the Settling Column Method for a Heterogeneous Population of
Particles

An actual cell sample contains a distribution of cell sizes, as shown in Figure 4.5, and
thus is expected to have a distribution of settling velocities. The interpretation of the
settling velocity, as measured with the method described above, for a non-uniform
population of particles, is presented here.
Suppose the particle mixture has distribution of diameters, where each diameter is
represented by di, with i=1,…n where n is the number of different discrete particle sizes.
The sample concentration, Xo, can be represented by:
n

X o = ∑ x i ,o

4.11

1
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where xi,o is the concentration of particles in the mixture with diameter di. The analysis
presented in equations 4.3-4.7 for a homogeneous population of particles can be written
for each particle of diameter di, i.e.:

vi =

h( xi , f − xi ,o )

4.12

x i ,o t

Let v be the number-average settling velocity of the population, defined by:

1
v=
Xo

n

∑v x
i

4.13

i ,o

i =1

Substitution of Eqn. 12 into Eqn. 4.13, and rearranging, yields:

v=

n
h  n

x
−
 ∑ i , f ∑ xi ,o 
X ot  i =1
i =1


4.14

Substitution of Eq. 11 for the initial concentration, Xo, and the equivalent expression for
the final concentration, Xf, yields:

v =

h
(X f − X o )
X ot

4.15

The right hand sides of Eqns. 4.15 and 4.7 are identical; thus the measured population
settling velocity, v, is identical to the number-average velocity, v .
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CHAPTER V
SCALEUP OF INCLINED GRAVITY SETTLER FOR RETENTION
OF ANIMAL CELLS AND ALGAE DEWATERING

5. 1 Introduction

A small-volume inclined gravity settler made of borosilicate glass for cell retention used
in bench-top perfusion cell culture bioreactor was described in Chapter III. The capacity
of the settler tested was 1.6L/day. This flow rate is high enough for conducting benchscale bioreactor perfusion culture but not for large scale industrial perfusion culture,
which is up to 3600 L/ day.4 This chapter focuses on the scale-up of the design.

Besides the cell retention application for mammalian cell perfusion culture systems, the
inclined gravity settler is also tested with algae dewatering purpose. Since some algae
cells have similar properties to mammalian cells. The two kind of cells both have
diameters around 10um and density close to water. For perfusion cell culture systems the
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inclined gravity settler is used for to remove spent media and return the retained cells
back to bioreactor. For algae culture dewatering purpose, the gravity settler is used to
remove water and concentrate the algae culture.

Whether the application is large-scale biopharmaceuticals for mammalian cells, or algae
dewatering, several modifications should be made from the small-scale device. The first
is the material of construction. Because of the brittleness of glass, the material used for
constructing the small-scale settler, glass, is not practical for large-scale use. An
incidental impact or pressure shift might break the glass wall of the settler and terminate
the culture. It is also more difficult to manufacture using glass.

Polycarbonate is light-weight compared to glass or steel. It is tough (virtually
unbreakable), glass-like transparent and autoclavable.102 It can be extruded into desired
form like many other thermoplastics. Polycarbonate sheet can be easily machined with
standard metal tooling machines and is dimensionally stable. FDA compliant grade is
available, which is critical for cell culture processes producing therapeutical
pharmaceuticals for human uses. It is a better material than glass for making the gravity
settler provided that the cell retention efficiency is not adversely impacted.

The second modification concerns is about the geometry and outlet arrangement on the
settler. The dimension of the settler will be scaled up by increasing the length and width.
The thickness will be kept similar as the small volume inclined gravity settler. As shown
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in Figure 5.1, the outlet of the concentrated stream will be moved to the lower end the
settler.

5.2 Materials and Methods

5.2.1 Device Description

Inlet III

Inlet II
Inlet I

Separator

Port I to
harvest
Port II to
bioreactor

Side view

Top view
Figure 5.1 Schematic of the 10L/day inclined gravity settler.
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Air vent

Two settlers were made and tested, which are made of 9.5mm thick polycarbonate plate
(McMaster, Aurora, OH). The first one as shown in Figure 5.1 was built based on the
design shown in Figure 3.2. The fundamental difference between them lies in the outlet
design. For the previous one as shown in Figure 3.2, the outlet for cell returning to
bioreactor is located on the lower plate of the settler next to the lower end of the inclined
gravity settler as shown in Figure 3.2. For the new one, both outlets are located at the end
of the settler and the outlet to bioreactor is underneath the outlet to harvest tank. The
change was made because cells tended to accumulate at the joint area between the outlet
and lower plate (Figure 3.2) due to the slow flow rate at that area. Another reason for the
change is to facilitate stacking the individual settlers to a group for supporting large scale
culture. The cell separation capacity is adjusted by selecting different inlets along the
Inlet
Vent

Port I to bioreactor

Port II to harvest

Figure 5.2 Side view of inclined gravity settler for algae dewatering.
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longitude axis.

The second design shown in Figure 5.2 has inlets only at one position near the upper end
of the settler. The inlet position is located on the side end of the settler to make it easier to
stack. One more difference is that there is no separator between the two outlets like that
shown in Figure 5.1 since it was found that the separator was not necessary during the
test with the first prototype.

5.2.2 Cell Line and Media

Hybridoma HB159 cells were cultured in BD CellTM Mab serum free medium (BD
Diagnostic Systems, Sparks, MD). The media was supplemented with 0.1% Pluronic F68
(Sigma, St. Louis, MO) for bioreactor culture. No other components were added or
adjustments made to the media during the culture process. Algae, Scenedesmus
dimorphus, is used for the algae dewatering test. Both hybridoma and algae cell numbers
were determined using hemocytometer.

5.2.3 Hybridoma Perfusion System and Culture Protocol

The perfusion culture system is shown in Figure 5.3. A 2 L B.Braun stirred bioreactor (B.
Braun Biotech) with 2 L working volume was used. A four-gas control module was
applied to maintain the DO at 50%. The set point of pH was 7.2 but it fluctuated between
6.8 and 7.2 since no base or acid was supplied during the culture.
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Cells were at first cultured in T-flasks in a humidified 5% carbon dioxide incubator at
37oC. Cells in exponential growth phase were inoculated in the stirred bioreactor. The
culture was started as batch culture then transitioned to perfusion culture in order to
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achieve high cell concentration for the short-term recycle cell retention test. The actual
perfusion flow rate was 1L/day. Viable cell density was maintained over 1x107 cells/mL
in the bioreactor. The flow rate from the outlet port I is taken as virtual perfusion flow
rate. It is called virtual perfusion flow rate because the system is not really perfused with
that amount of fresh media but it can show the real capacity that the retention device can
process. In order to simplify the discussion, we use the term “perfusion” to replace the
“virtual perfusion”

5.2.4 Algae Perfusion System
At first the algae were in cultured in 150 mL Erlenmeyer flasks and then transferred to 2
L Pyrex bottles. Finally 5 L of algae suspension was collected and maintained in a 10 L
Pyrex bottle sitting on a stirring plate for the algae dewatering test with the scaled up
inclined gravity settler. The tested algae culture was maintained in room temperature and
aerated with air supplemented with less than 5% CO2. The agitation speed of the stirring
bar was adjusted to keep all algae in suspension. The experimental set up is shown in
Figure 5.4 and Figure 5.5A.

5.2.5 Calculations

The cell retention rate, R, is defined as:
R=

XR − XO
× 100 %
XR

5.1
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where XR is the cell concentration in the bioreactor; XO is the cell concentration in
the overflow stream that exits the gravity settler via port I to the harvest tank.

Bioreactor
Sampling

Gravity Settler

Harvest Sampling

10 L Bottle

Figure 5.4 Setup of algae dewatering with the gravity settler.

If the two outlets of the settler are combined, then cell concentration in the combined
outlet stream will be equal to the cell concentration in the bioreactor, XR , during
steady state. Let the average cell concentration in the settler be Xa; then the total
cell number in the settler is Xa*V, where V is the working volume of the inclined
gravity setter The speed at which the cells leave (and enter) the settler is F* XR
where F is flow rate of cell suspension entering the settler The average time needed
to remove these retained cells is defined as the cell residense time in the settler,
given by:
T =

V • Xa
F • XR

5.2
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Figure 5.5 A. Algae dewatering setup with the inclined gravity settler B. Settled down algae formed a thin layer sliding downwardly during steady
status. C. Contrast view between concentrated stream and clarified stream at outlets.

The algae concentration ratio, C, is defined as:

C=

XU
XR

5.3

where XR is the cell concentration in the bioreactor; Xu is the algae cell concentration
in the harvest stream.

5.3 Results and Discussion

5.3.1 Hybridoma Cell Retention Test
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Figure 5.6 Cell retention at different entry point vs. perfusion rate for HB 159 Hybridoma
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Table 5.1 Viable cell retention rate vs. L and perfusion amount.

Inlet I

Inlet II

Inlet III

L (cm)

16

33.5

57

Perfusion amount (L/day)

5.8

10.8

15.8

Viable cell retention rate (%)

99

98

96

Figure 5.6 shows the hybridoma cell retention at different perfusion amount using the
settler shown in Figure 5.1. The maximum perfusion rate was achieved is17.28 L/day
with 90% viable cell retention efficiency. This is about a 10-fold improvement in
capacity compared to the bench top device described in Chapter 3. This result verified
that this inclined gravity settler is scalable.
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Figure 5.7 Actual cell retention capacity and predicted cell retention capacity based on settler length (cell
retention ≥ 96%).
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Surprisingly, the cell retention capability (maximum perfusion account with cell retention
over 95%) is not linearly proportional to the length, L, as predicted by Equation 3.2.
Hereof L is the distance between the entry point and upper end of the separator. As
shown in Table 5.1 and Figure 5.7, the amplitude of cell retention capacity increase is
less than that of the length. It is contradicted to the prediction: cell retention capacity is
linearly proportional to the length.

The observed discrepancy with the theoretical prediction is mostly likely caused by the
different cell residence times in the gravity settler as shown in Figure 5.8. While the
supernatant residence time is almost unchanged, the cell residence time is approximately
proportional to the length. This means the sliding speed of the settled cells almost stays
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Figure 5.8 Average residence time of cells vs. supernatant
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Supernatant

constant while the linear velocity of cell suspension or supernatant increases along with
the perfusion rate. The longer residence time of settled cells can cause cell accumulation
in the settler. Upper layer of cells of the settled cells will be dragged by the hydraulic
force due to the difference of movement speed between settled cells and the fluid. From
direct visual observation through the transparent upper surface of the gravity settler, the
settled cells slide down like traveling dunes. The uneven distribution would induce
turbulence in the laminar flow, and then reduce the cell retention efficiency. This result
indicates that the inclined gravity settler can not be linearly scaled up by simply
increasing the length, which would lower the cell retention efficiency per unit area.

Another important issue that should be taken into account is the residence time issue of
viable cells. The environment in the gravity settler is not suitable for cell growth since
there is no control over DO and pH. The residence time of viable cells in the settler
should not be too long. It was found cell growth and antibody productivity were not
impacted significantly when the residence time in the settler was less than 1.5 hours.23, 28
When the third inlet was used, the residence time of viable cells in the settler we tested
was 1.2 hours as shown in Figure 5.8, which is still acceptable for supporting a perfusion
culture system as a cell retention device.

Further increase of the length is not practical, which will increase viable cell residence
time. Therefore the length of the downward flow inclined gravity settler should not be
over 60 cm.
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For retention over 95%, the maximum perfusion amount of cell suspension the settler can
handle is 15.8L/day. If the perfusion rate is 1/day, then the maximum working volume of
the bioreactor this settler can support is 15.8L. The working volume of the settler used
here is 361 mL (b=0.66cm, w=9.6 cm and LIII=57) which is about 2.3% of the bioreactor
working volume, 15.8 L, it can handle. The maximum thickness of the settler should not
be increased freely since As shown in equations 3.1 and 3.2, the increase of thickness, b,
of the settler is negligible to the cell retention capacity and the volume of gravity settler
working volume should be less than 5% of the bioreactor working volume. Therefore the
maximum thickness of the downward-flow inclined gravity settler we recommend here is
1.3 cm.

Although the length and thickness can not be increased at will, the width, w, can be
increased with no limitation as long as enough inlets are arranged for even distribution of
flow. If taking the convenience of operation into consideration, the maximum of width
can be set as 150 cm, which turns out the maximum capacity a single unit of the settler is
246 L/day, while the working length is 57 cm and the thickness is 0.66 cm. For further
scale up, multiple single settler as shown in Figure 5.2 can be stacked up, with which
there is no limitation virtually for the maximum capacity.

The retail price of 0.5 cm thick polycarbonate sheet, which was used in building the
settler, is $51/m2. To build a settler with 80 L/day capacity, the total size of
polycarbonate sheet needed is 0.6 m2 with cost $31. The material cost will be $40 by

66

Concentration Ratio (Harvest to Bioreactor)

5.0

4.5
n=3
4.0

3.5

3.0
n=3
2.5

2.0

1.5

1.0

0.5

0.0

18+2 mL/min

12+2mL/min
Flow Rate (mL/min)

Figure 5.9 Concentration ratio of algae dewatering test. Error bar shows standard deviation. (12 + 2
mL/min denotes that the clarified stream flow rate was 12mL/min and the harvest
stream flow rate was 2 mL/min; 18+2 mL/min denotes that the clarified stream flow
rate was 18mL/min and the harvest stream flow rate was 2 mL/min)
adding 30% cost for the outlet part. We estimate the manufacturing cost is $100 for large

quantities. Then the cost for producing a unit with 80L/day is $140.

5.3.2 Algae Dewatering Tests

Results with algae are shown in Figure 5.5 and 5.9. As shown in Figure 5.5 C using the
settler shown in Figure 5.2, it is visually apparent that the algae concentration in harvest
stream is much higher than that in the clarified steam. Figure 5.5 B shows steady status of
the algae dewatering process. Settled algae formed a thin film and move downwardly
along the inclined settler smoothly. The process appeared to operate smoothly over a
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period of 3 weeks at which point it was terminated due to a leak in the settler. The
quantitative results are reported in Figure 5.9. 4-fold increases in concentration was
achieved when the flow rate is 12 + 2 mL/min which denotes that the clarified stream
flow rate was 12mL/min and the harvest stream flow rate was 2 mL/min. This implies,
for achieving a given amount of dry algae mass, the volume is about 25% concentrated
algae suspension needed to be processed compared to regular unprocessed algae
suspension. When the total flow rate increased from 14ml/min to 18+2 mL/min (clarified
stream flow rate was 18mL/min and the harvest stream flow rate was 2 mL/min), the
concentration ratio decreased to 2.7-fold. To determine which flow rate will be used for
practical application it depends on the algae dry mass recovery rate as shown in Figure
5.10, in which we assume the algae concentration is 1x108 algaes/mL concentration in the
algae suspension to be processed, which is transferred to 2 g/L dry mass (data from lab
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Figure 5.10 Recovery of dry algae mass per square meter of the inclined gravity settler from the
harvest stream. Error bar shows standard deviation.
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communication). The recovery rates are almost same for two flow rates. So increasing the
total flow rate from 14 to 20 mL/min did not increase the amount of algae recovery. At
same level of recovery rate, higher flow rate means higher energy consumption in
pumping system. More tests need to be conducted to determine the optimal flow rate for
maximum algae recovery rate.
When the flow rate is 12+2 mL/min, the expected recovery rate of algae mass is 424 g
dry wt/day/m2. If we assume the dry algae oil content is 50%, the area of inclined gravity
settler needed to collect enough algae for producing 1 ton oil per day is 4761 m2 which is
69m x 69m area. It is more than 1 acre. To reduce the land usage, a multiple layer of
design should be considered. Meanwhile the manufacturing cost can be reduced
significantly. For any middle plate in a multi-plate settler will function as upper piece and
lower piece, which is almost 50% building material saving and the materials for the
middle pieces can be much thinner than that of the one in a single layer settler, which
acts as frame as well to support its own weight.
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CHAPTER VI
CELL RETENTION WITH ACOUSTIC FILTERS

6.1 Introduction

In Chapter III, IV and V, the first approach of cell retention using an inclined gravity
settler was presented. In this chapter, two modifications of currently available ultrasonic
filters for performance improvement will be described.

The range of ultrasound frequency for applications in cell retention is 0.5--3 MHz.
Particles mainly undergo two forces in the ultrasonic standing field, “primary acoustic
force” and “secondary acoustic force”. When particles in suspension are exposed to a
resonant acoustic wave field, the particles experience a time-averaged force known as the
primary acoustic force. It moves the particles to the pressure nodal planes or antinodal
planes determined by physical properties of the particle and carrying fluid. This force is
related to compressibility and density of the particles and the carrying fluid and can be
calculated using the following equation:103, 104
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Fac = 4πR 3κEac sin( 2κx ) F

6-1

where κ is the wave number across the acoustic filter, Eac is energy density within the
suspension, x is the distance of the cell from the nearest pressure nodal plane, R is the
particle radius, and F is the acoustic contrast factor. This factor F is characteristic of the
suspension and is given by:103, 104

1 5ρ − 2 ρ f γ p
F= ( p
− )
3 ρ f + 2ρ p γ f

6-2

Where ρP is the density of the particle, ρf is the density of carrying fluid, γf is the
compressibility of carrying fluid, γp is the compressibility of the particle. Movement of
particles to either the pressure nodal planes or antinodal plane is determined by the sign
of F.

Particles also experience forces due to local scattering of the acoustic field by nearby
particles, known as the secondary acoustic force. This force between particles exists
because of the reflection of the acoustic field by one particle to the other particles and is
given by:

γ
γ
VV
Fs = ρ c f Eac γ (1 − p1 )(1 − p 2 )( 1 22 )
γf
γf d
2
f

2
f

2

6-3

2
f

Where cf is the speed of sound in the fluid, f is the frequency of the applied ultrasound, V
is the particle volume, d is distance between two particles. This equation is valid if both
particles are less compressible or both particles are more compressible than the carrying

71

fluid.18 Obviously it is valid for suspensions of particles made of the same kind of
material.

This force causes the nearby particles to aggregate to form clusters and drive the
concentrated cells to the local minima of pressure amplitude within the pressure nodal
planes.105 The particle cluster can either stay in the ultrasonic field, or drop out of the
field when the gravity force is equal to or bigger than the hydraulic drag force. Various
types of acoustic filters using this approach have been used to retain cells in
microorganism fermentation or animal cell culture.16,

17, 19-21, 106-110

Commercially

available acoustic filters utilizing standing ultrasonic waves to retain mammalian cells
have been successfully used in large scale perfusion culture with capacity up to 1000
L/day.108, 109, 111

A porous media placed within the acoustic filter has been shown to increase the particle
retention efficiency.18,

112, 113

The interaction of the incident plane waves with waves

reflected from the fibers of the porous mesh enhances the capture of particles in the
acoustic filter. A single fiber model has been used to explain the mechanism of the
particle retention improvement effect of porous mesh in the acoustic standing field.114-116
A single particle can be captured by a single fiber of the porous mesh due to the
secondary force between the fiber and particle. When a particle cluster formed under the
primary and secondary force is larger enough, it can be blocked by the limited opening
spaces of the porous mesh.

18
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The enhancement of mammalian cell retention by filling acoustic filter with porous mesh
is studied in this chapter. In contrast to a mechanical filtration process, the porous mesh
has a much larger pore size compared to cell size.

The acoustic transducers are glued directly to the glass wall or frame of the commercially
available acoustic filters for mammalian cell culture.17, 105, 107, 108, 110, 117-119 Compared to
this rigid attachment of transducer, Dr. Feke’s group at Case Western Reserve University,
used a flexible approach to attach the transducer to the acoustic filter.18, 112-116, 120, 121 The
acoustic transducer attachment methods, rigid and flexible, are also compared in this
chapter. The objective is to increase the cell retention capacity per unit of power input
compared to available acoustic filters via this approach.

6.2 Materials and Methods

6.2.1 Cell Line and Medium

T10B9 Hybridoma cells (ATCC) were used for the cell retention tests conducted within
the acoustic filter. A serum free medium, BD Cell Mab Medium Serum Free, (BD
Biosciences - Advanced Bioprocessing) supplemented with 0.1% Pluronic F68 (Sigma,
St. Louis, MO) was used for cell culture. Cells were cultured in T-flasks first, then
transferred to a 2-L B.Braun stirred bioreactor and the working volume was 1.5 L.

73

6.2.2 Experimental Setup

Four acoustic filters were tested in this study. As shown in Figure 6.1121 and 6.2, the first
design using flexible attachment method is essentially the same as that made by David
Rusinko for retention of polystyrene particle, with the exceptions that the polycarbonate
was used for making the frames instead of acrylic or polyethylene, and that silicon sheets
replaced latex sheets.121 The 10mm thick transducer (PZT, Navy Type I, Model EC-64,
EDO Electro Ceramics, New York, NY) and the glass reflector shown in top left of the
photo, are attached to the central frame by two fixing frames. Resonant frequency around
1.1 MHz was used for the excitation to maintain standing wave field in the acoustic filter.
The acoustic filter inner volume is 13 mL. Figure 6.3 shows the experiment setup using

Figure 6.1 Schematic of the first acoustic filter tested for cell retention. (Modified form of model by David
Rusinko).

this device called “single chamber acoustic filter”.
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Figure 6.2 Photo of the ultrasonic chamber (First filter, Courtesy of Dr. Feke’s Lab at CWRU).

The second acoustic filter tested as shown in Figure 6.4 is made of 2 mm thick
borosilicate glass. The acoustic filter has two chambers (called “double chamber” device)
with equal dimension, which is similar design by Doblhoff-Dier, et. al.16 Dimension of
each chamber of the double chamber acoustic filter is 150 x 50 x 22 mm (height x width
x thickness). The inner volume of each chamber is 152 mL. The separator is 10 micron
thick polyethylene film. The acoustic impedance of polyethylene (1.79 MRayls) is close
to that of water (1.48 MRayls at 20 oC) and it is thin so the sound energy loss across the
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Figure 6.3 Cell retention test with the first acoustic filter with single chamber.

separator is minimal. Four pieces of 25 x 25 x 1 mm piezoelectric lead zirconate titanate
transducers (APC 880, American Piezo Ceramics, Inc., Mackeyville, PA) with frequency
around 2.1 MHz were used for the excitation to maintain resonance in the acoustic filter.
The transducers were directly attached to the glass carrier.The side wall, transducer
carrier and reflector were all made of 2 mm borosilicate glass. The chamber next to
reflector is the active chamber. The flow distributor is made of 1 mm thick phenolic sheet.

Separator
Mesh

APC 880 Transducer

35mm
50 mm

65 mm
Reflector
Cooling chamber
Flow distributor
Cooling water Cell Suspension
Figure 6.4 Acoustic chamber coupled with water cooling chamber (Second, third and fourth
filter.
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The diameter of holes on it is 1.2 mm and the distance between each hole is 3 mm.

The third acoustic filter is also a double chamber with the same design as the second
acoustic filter but with smaller dimensions called the “small double chamber acoustic
filter”. Dimension of each chamber of this filter is 150 x 22 x 22 mm (height x width x
thickness). One piece of transducer was used with dimension 50 x 18 x 1mm (height x
width x thickness). Inner volume for each chamber is 59 mL. The separator material is
127 um thick TPX (polymethylpentene) film which is not only autoclavable and FDA
compliant but also stronger than polyethylene. Like polyethylene, TPX material also has
acoustic impedance (1.84 MRayls) close to water so minimal ultrasonic energy loss
occurs across the TPX film.

For the second and third acoustic filters, the piezoelectric transducer was attached on a
piece of 2 mm thick glass carrier using low viscosity glue, Loctite Super Bonder 420
(Loctite, Avon, OH) with viscosity of 2 cp. The low viscosity glue can minimize the
thickness of the gap between the piezoelectric transducer and glass carrier, in order to
minimize the power input needed for cell retention capacity.

The fourth acoustic filter has same dimension as the third acoustic filter. As mentioned in
Rusinko’s work a flexible piezoelectric transducer attachment approach can reduce power
loss due to transverse vibration of the transducer and the absorption due the carrier
layer.121 The fourth acoustic filter with double chambers was constructed with the
transducer flexibly attached on the cooling chamber side (“flexible double chamber”). In
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this experiment the piezoelectric transducer edge was glued on a piece of 0.5 mm silicone
membrane. All other features are identical to the third acoustic filter. The reason to build
the third and forth acoustic filter is that it is easier to keep the suspended transducer
parallel to the reflector plane in a device with smaller dimensions compared to the
original large double-chamber device. Experiments with same parameters were
conducted with the third and forth acoustic filters for evaluating the effect of the rigid vs
flexible transducer attachment method.

Figure 6.5 shows experimental setup for tests conducted with the second, third and forth
acoustic filters. Temperature of water bath was 35oC and the cooling water was degassed.

Gas Module

RS
Temp
pH
DO

Sample Collection

Oscilloscope

Water bath

Acoustic
Chamber

Power
Amplifier

2 L Bioreactor

Signal
Generator
Figure 6.5 Experiment setup of cell retention test with double chamber acoustic filters.
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Control
Tower

Temperature in bioreactor was maintained at 37 oC. The flow rate of cooling water is
double that through the active chamber. Cell density in the bioreactor is 1- 1.2 million
cells/mL with over 90% viability.

The transducers were driven by an ENI 240L RF Power Amplifier (ENI Co., Rochester,
NY) with signal input from a HP 33120A signal generator (HP, Loveland, CO). The
voltage and current crossing the transducer were measured by a TDS 420 oscilloscope
(Tektronix, Beaverton, OR). The resonance status was evaluated by the power factor, the
cosine value of phase angle between voltage and current. For all experiments conducted,
the power factor was over 90% on average. The power input is calculated from the
following equation:

P = VI cos θ

6-4

Where P is the power input, V is the voltage and I is the electric current. θ is the phase
angle between voltage and current and cosθ is the power factor. The power input is the
average value over the time period of the measurement.

The porous mesh used to fill the acoustic filters is reticulated polyester with pore size
1250 microns and the porous mesh was made of polyurethane (Foamex International Inc.,
Media, PA). The wires conducting power to transducer were attached to the transducer
with rosin core solder (Alpha Metals Inc, Jersey City, NJ). The melting point of the
solder is 190.6 oC. The transducer’s Curie Point is 310 oC. The maximum operating
temperature for the transducer is Curie point/2, which is 165 oC.
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6.2.3 Analytical Methods

Cell density and viability were determined using hemocytometer count and trypan blue
exclusion method. Samples from the collection flasks were gathered during the quasisteady period assumed to be reached after four residence times after the changes in
operating condition. The cell retention rate, R, is defined as:

R =

XR − XO
× 100 %
XR

6-5

where XR is the viable cell density in the bioreactor; XO is the viable cell density in
the effluent from the acoustic filter at the point of sampling.

6.3 Results and Discussion

Figure 6.6 shows the cell retention results using the single chamber filter. Significant
improvement of cell retention capacity for the acoustic filter filled with porous mesh
compared to the empty one was noticed at the highest tested linear flow rate of cell
suspension, 1.6 mm/s. The cell retention rate of chamber filled with porous mesh is about
3-fold that of the one without mesh. The effect of mesh is not significant when flow rate
is at the lowest tested, 0.25mm/s. This is because the power input is high enough at the
low flow range to trap the cells at the nodal planes. With higher flow rate, the difference
becomes more apparent since the power input is not enough to hold most the cells at the
nodal planes in the absence of the porous mesh. At these two flow rates (0.75mm/s and
1.6mm/s), the higher retention rates confirmed the retention enhancement capacity of the
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Figure 6.6 Cell retention for the two designs at three flow rates. The power input for the chamber with
mesh is 1.12 W/mL, and 1.15 W/mL in the absence of mesh (the first chamber).

fine particles, like mammalian cells, with acoustically energized porous mesh fibers.18, 112,
114-116

In Doblhoff-Dier et al.’s tests with a double chamber acoustic filter, with power input
density of 0.4 W/mL, nearly 100% of cell retention was achieved at 1 mm/s flow rate.16
The power input density with our single-chamber acoustic filter the power input density
is much higher, about 1.1 W/mL but the cell retention rate was lower than 90% at 0.25
mm/s flow rate. For higher power input and lower flow rate with the single chamber
acoustic filter, lower cell retention efficiency was achieved compared to the double
chamber acoustic filter. The major barrier to achieve high retention efficiency with our
single-chamber acoustic filter probably is natural convective flow. Filling the acoustic
filter with porous mesh could not offset this effect even at the lowest flow rates tested.
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The convective flow is caused by temperature gradient induced by heat generated from
the acoustic transducer, which disrupts the lineup of retained cells.118, 122

Figure 6.7 shows the cell retention results with the second acoustic filter (large double
chamber). Each curve denotes the cell retention under a range of power inputs with a
given flow rate. As expected, retention increased with power input for each linear
velocity. With the aid of the cooling chamber this device achieved a 95% cell retention,
at 1 mm/s flow rate with 0.3 W/mL, without porous mesh, which is in the same range as
the result reported by Doblhoff-Dier et al., which was 95% retention with 0.28 W/mL.16
For perfusion cultures, more than 95% of viable cell retention is desired, so we select the
first point above 95% retention on the curves as the points to compare power

100
90
80

Cell Retention (%)

70

14%
60

39%
50
40

36%
30
20
10
0
0

0.05

0.1

0.15

0.2

0.25

0.3

0.35

0.4

0.45

Power Input (W/mL)
0.5mm/s without mesh

0.5 mm/s with mesh

0.75 mm/s without mesh

0.75 mm/s with mesh

1.0 mm/s without mesh

1.0 mm/s with mesh

Figure 6.7 Cell retention comparison for acoustic filters with or without porous mesh at different flow
rates vs. power inputs (Third acoustic filter).
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consumption but the two points to be compared must be as equal as possible. Compared
to the results achieved with acoustic filter without porous mesh filled, the cell retention
achieved in acoustic filter with porous mesh filled, for reaching the similar level of cell
retention, power input was reduced 36%, 39% and 14% respectively for flow rates
0.5mm/s, 0.75mm/s and 1mm/s respectively. These results confirm that for reaching
same level of cell retention efficiency less power input can be reduced by filling the
acoustic filter with porous mesh. Likewise at the same level of power input and linear
velocity, the presence of the porous mesh increased cell retention.

Visual observation indicates that the fibers of the porous mesh can help stabilize the
clustered cells in the acoustic filter by two mechanisms. First, the porous mesh acts like a
matrix to which the cells loosely attach in the ultrasonic standing wave field. Second,
although the pore size of the porous mesh is about two orders of the magnitude larger
than that of the single cell, the size of some cell flocs formed in the resonating sound field
is bigger than the mesh pore size, and thus the flocs may be trapped in the mesh.

Figure 6.8 shows cell retention for the fourth filter. For the same retention efficiency
(95%), the fourth filter with the suspended transducer used 46% less energy than the third
filter with the rigidly attached transducer. Since there is no direct rigid contact between
the piezoelectric transducer edges and the acoustic filter frame, the transverse mode
vibration of the piezoelectric transducer is minimized. And the energy loss due to
attenuation and reflection caused by the glass carrier layer is also eliminated.
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Figure 6.8 Cell retention test for no porous mesh filled acoustic filters with different transducer affixing
modes. Flow rate of cell suspension was 0.5mm/s (Fourth filter).

When the voltage across the transducer was increased from 600mVpp (corresponding to
0.38W/mL for the fourth acoustic filter with rigid transducer attachment) to 650mVpp,
the solder for fixing the conducting wire to the transducer surface started to melt. This
means the transducer is depolarized since the ½ Curie Point (155 oC, above which the
transducer depolarizes) of the transducer is lower than the solder melting point (190.5 oC).
This implies the power input cannot be increased freely otherwise the transducer is under
risk of damage. A portion of the power input through the transducer was transferred into
heating within the transducer. It is not only an issue of energy waste but also seriously
limited the operating range of the acoustic filter. Here the operating range is defined as
the minimum power input needed to achieve 95% cell retention to the maximum power
input can be tolerated by the transducer.
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The solder melting point is 35.5 oC higher than the ½ Curie Point so before the solder on
the transducer melted the temperature at the point might have already surpassed the
maximum allowed operating temperature of the transducer. Suppose the highest power
input points we tested are the highest power input can be reached without damaging the
transducer. Then the operating range of power input for the flexible transducer mode is 1340% (point A to D in Figure 6.8), while the power operating range of acoustic filter with
transducer rigidly affixed is 1-120% (point B to C in Figure 6.8). It is almost three times
than the latter. When using the flexibly attached transducer compared to the one with
rigid attachment, the maximum power input was increased at least 50% (Point C to D in
Figure 6.8) before depolarization occurred.
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CHAPTER VII
IMPACT OF EXPOSURE OF ULTRASONIC STANDING WAVES ON CELL
GROWTH AND ANTIBODY PRODUCTION

7.1 Introduction

In chapter VI, cell retention in acoustic filters was shown to be enhanced in the presence
of porous mesh. It was found that there is no detectable negative impact of ultrasonic
field on cell viability and antibody productivity in short-term exposure time, i.e. less than
an hour.19, 123

16

Ultrasonic filters have been successfully applied in perfusion culture

systems as cell retention devices.20, 21, 106-108, 118, 119 When used as a cell retention device,
cell residence time within the ultrasonic filter chamber is less than an hour.

The supposed cell retention device can be eliminated in a perfusion system if the
ultrasound is applied to the bioreactor to retain cells within the bioreactor. The impact of
ultrasonic standing waving on cell growth and productivity during long-term exposure
was investigated.
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7.2 Materials and Methods

7.2.1 Cell line and Medium

The cell line used is a hybridoma (mouse, ATCC HB-159), which produces
immunoglobulin against H-2 Kd. The cell culture medium is RPMI 1640 supplemented
either with fetal bovine serum or without serum (serum free medium). Cells were
maintained in 250 mL T-flasks in 5% carbon dioxide incubator.

7.2.2 Analytical methods

Viable and non-viable cell concentrations are determined using a hemocytometer with
trypan blue exclusion method. A mouse IgG ELISA kit (Alpha Diagnostic International,
San Antonio, TX) was used to measure the antibody concentration.

7.2.3 Experimental Setup

The same acoustic filter shown in Figure 6.1 and 6.2 was used. The experimental setup is
same as shown in Figure 6.3 was used for short term impact test. Cell suspension was
kept in a stirred bottle and pumped through the acoustic filter. There was no control of
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temperature, DO and pH in the test. As shown in Figure 7.1, a 1 L B.Braun stirred
bioreactor (B. Braun
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Figure 7.1 Bioreactor system setup for long term impact test

biotech, Allentown, PA) with 1 L working volume coupled with the acoustic filter was
used to test the long term impact of ultrasonic standing waves on cell growth and
productivity. Using the bioreactor system the recycled media can be maintained with
stable pH, Temperature and DO. The left side of Figure 7.1 shows the ultrasonic signal
generating system. The ultrasonic signal is generated by the signal generator and is
amplified by the power amplifier. The amplified high frequency signal drives the PZT
transducer to produce ultrasonic waves. A power meter is used to check whether the
resonant waves are occurring inside the chamber. On the right side of the figure is a
traditional bioreactor system, which was used to control DO, temperature, and pH for the
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cell suspension that flows through the ultrasonic filter. The cells were first inoculated in
the traditional bioreactor, and after the lag phase, the cell suspension was pumped
through the acoustic chamber. The cells were then retained by the ultrasonic field in the
chamber.

7.3 Results and Discussion

7.3.1 Effect of short-term exposure to ultrasonic fields in controlled
environment

Here “short-term” means time range less than a day, in contrast to several days for
regular cell culture. Figure 7.2 shows the results of experiment done by Paul
Grabenstetter, who did preliminary research work on cell retention using the acoustic
filter filled with porous mesh.
From Figure 7.2 we can find that, after a short period of exposure to the ultrasonic fields
(5 hours), the impact of exposure to the ultrasonic standing waves on cell viability is
negligible. This result provided the basis for proposing a long-term “ultrasonic
bioreactor”.
Figure 7.3 shows the results of another set of short-term exposure experiments. The flow
rate was 30 ml/min and the acoustic filter contained the mesh. In this short term
experiment Vsg was set to 150 mVpp at which level cells can be effectively retained in
the ultrasonic filter.
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The first two bars show cells cultured in serum-free medium. 4-hour exposure to
ultrasonic field significantly reduced cell viability, by 70%. Meanwhile the viability of
the control experiment with voltage applied did not decrease at all after 24 hours. This
implies that the ultrasonic field at the power density needed to retain cells could stress the
cells and cause cell death.
For the second group of bars, the cells were cultured in a 10% serum medium. After 4
hours exposure to ultrasonic field, the cell viability was not influenced. This is consistent
with result presented in Figure 7.2. It is apparent that the serum in the medium provides
some protection to the cells exposed to the ultrasonic standing waves. However, after 16
hours, the cell viability decreased more than 80%. This means the serum can only delay
but not eliminate all the negative impact of ultrasonic field on cells.
10
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Figure 7.2 Effects of exposure of 5 hours to ultrasonic fields on viable cell grown in PRMI 1640 media
supplemented with 10% serum when the acoustic transducer is powered with three variation of voltage.
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Figure 7.3 Effect of exposure to ultrasound standing wave field on cell growth without control of DO and
pH (Vsg=150mVpp).

Both experiments about short time exposure to ultrasonic field were conducted without
temperature, DO and pH control. It is possible that the uncontrolled culture conditions
contributed to the quick cell death. In order to identify the impact of these factors’
potential negative influences on cell growth, experiments for investigating the influence
of temperature, DO and pH control were conducted.

7.3.2 Long term exposure to the ultrasonic field in controlled
environment

In this set of experiments, the ultrasonic filter was combined with a 1 L B.Braun
bioreactor with which DO, pH, and temperature was well maintained around the set point.
Although the DO and pH number in the ultrasonic filter were not able to be controlled,
they were indirectly maintained by circulating the culture medium from the bioreactor
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Figure 7.4 Long term exposure to ultrasonic wave for cells raised in serum free medium
(a) Cell growth curve for batch culture in serum free medium without exposure to ultrasound field; (b)
Cells cultured with serum-free medium in 1L bioreactor combined with ultrasonic filter (Vsg=600mVpp).

where the two parameters were well controlled. In this way, we can figure out if the two
parameters at uncontrolled situation are the cell death cause when the cells are exposed to
ultrasonic field.

Figure 7.4 (a) shows the cell growth curve for control experiment. The cells were
cultured with a serum-free medium in 1 L B.Braun bioreactor. 1.4 million cells/mL
concentration was achieved. This result is typical for this type of system. A culture was
conducted in the system coupled with the ultrasonic filter (Figure 7.4(b)). At first cells
were inoculated in the bioreactor. Thirty six hours after inoculation, flow of the cell
suspension through the acoustic filter was initiated. Every 12 hours, one sample was
taken from the traditional bioreactor with the ultrasonic field on. The cells were killed
quickly within 12 hours, as shown in Figure 7.4(b). In Figure 7.4(a), at about the 76th
hour during the culture, the viable cell density is above 1 x 106 cells/mL, but in Figure
12(b), at about 76 hours, the viable cell density almost was zero. All cells retained in the
ultrasonic filter were flushed back to the bioreactor before sampling. It is noticed that the
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Figure 7.5 Temperature in the main stream and on the transducer surface in the ultrasonic filter
(Vsg=300mVpp)

sum of viable cell number and nonviable in the last sample is about equal to the sum of
viable and nonviable cells in the sample right before the ultrasonic filter was powered on.
This means that almost no cell growth happened. Viable cells just were killed in the
process.

From this comparison and the comparison shown in Figure 7.3, we can conclude the
ultrasonic standing waves at the energy levels we used in the experiments negatively
affect cell growth.

7.3.2.1 Temperature effects
To investigate whether cell death was caused by heat generation in the filter, we
measured temperatures in the system. Phosphate buffered saline (PBS) buffer was
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Figure 7.6 Viability and cell concentration after 24 hour incubation.

circulated through the ultrasonic filter shown in Figure 7.1 and the fluid temperature at
various points in the chamber was recorded. PBS flow rate in through the filter is
4.7mL/min, which is the minimum flow rate used for the cell retention tests. The
temperature was set to 37 oC in the traditional bioreactor. When the fluid reached the
lower inlet of the ultrasonic filter, the temperature of the fluid had been cooled down to
32 oC by the room environment. As shown in Figure 7.5, the temperature at the chamber
center was 33.5 oC and the temperature at the transducer surface was 34.5 oC, both during
flow conditions. When the flow fluid is stopped, the temperature at the surface rises to 39
o

C, which would not kill cells quickly. Actually the fluid is always moving in experiment

as shown in Figure 7.4, in which the temperature was not over 37 oC. Based on the
results we believe that excessive heat generation would not be a cause of cell death.
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Next, it was verified that the low temperature (33.5 oC) did not significantly affect cell
growth. Cells were cultured in 33 oC and 37 oC incubators with same inoculation for 24
hours. The result is shown in Figure 7.6. The difference in cell density and cell viability
between cells grown in different temperatures is negligible. Therefore, the slightly lower
than normal temperature in the ultrasonic filter should not have a significantly negative
impact on cell survival.

7.3.2.2 Effect of serum
In previous experiments (Figure 7.3) we have found the serum has some protective
effects on cells influenced by ultrasonic fields. Therefore, subsequent experiments were
done in the serum medium. Figure 7.7 shows the culture results with 10% serum medium
at different levels of power. At time=24 hours, the transducer was energized (except the
control experiment). Every 12 hours the bioreactor culture vessel for the control culture
experiment and the experiments with Vsg=40 mVpp were sampled and the concentration
reported in Figure 7.7. Because there is almost no cell retention in the ultrasonic filter
when Vsg=40 mVpp, there is no need to turn off the power and flush the system.
However, at Vsg=300 mVpp, sampling was done by the following procedure: the
transducer was turned off for 5 minutes, and the ultrasonic filter was flushed in reverse to
return the retained cells in the ultrasonic filter back to the bioreactor. Then a sample was
taken from the bioreactor and counted. After the sampling procedure was complete, the
transducer was turned on again.

95

Cell concentration (*1E5 Cells/ml)

14

12

10

8

6

4

2

0
0

20

40

60

80

100

120

140

160

180

Time (hour)
Control Viable Cell Concentration in 1 L bioreactor with 10% serum (Ultrasonic field is off)
Cell cultured with 10% serum in 1 L bioreactor combined with Ultrasonic filter ( Vsg=40mVpp, Fre=1.13MHz)
Repeat experiment for cell cultured with 10% serum in 1L bioreactor combined with ultrasonic filter ( Vsg=40mVpp, Fre=1.13MHz)

From Figure 7.7, we can see that the maximum viable cell densities and viabilities
decreased as applied voltage V increased. No threshold level of acceptable power was
observed; even at Vsg=40 mVpp where no cell retention occurs and exposure time to the
ultrasonic field is shortened, a detrimental effect on cell growth was observed. The
maximum signal generator voltage used in this set of experiment was 300 mVpp, at
which level of power input, cell concentration was more than tripled at 96 hours, while
the cells died out at 80 hours for culture shown in Figure 7.4. This difference is caused by
two reasons. The first is that culture shown in Figure 7.4 used 600 mVpp voltage with the
signal generator which is double of the latter. It is shown in Figure 7.7 that the higher
voltage of signal generator, the more negative impact on cell growth. The second is that
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the culture shown in Figure 7.4 was conducted using serum free medium while the
culture shown in Figure 7.7 used 10% serum medium. The presence of serum in the
medium provided the cells some protection from the sound stress.

Serum concentration was increased from 10% to 15% to see whether the higher
concentration serum would protect the cells from sound-induced damage. The ultrasonic
filter was combined with the 1 L bioreactor. The sampling procedure is similar as the
above experiment. The results shown in Figure 7.8 illustrate that cell growth and viability
are basically same for cultures with 10% and 15% serum supplement. The maximum cell
density achieved and growth period in both two culture runs are very close when the
signal generator voltage was 300 mVpp. This implies that further increase of serum
concentration in the culture medium cannot provide extra protection to the cells from
negative impact induced by exposing to ultrasonic field.

The antibody production at different levels voltage input with signal generator is shown
in Figure 7.9. The data come from the culture experiments shown in Figure 7.7 and
Figure 7.8. As shown in Figure 7.9 antibody production decreased drastically, over 50%,
when the voltage at signal generator is 40 mVpp. If take into account of the amount of
antibody existed in inoculum which volume was counted for 20% of final culture volume
the antibody production reduction is even higher compared to control culture. At this
level of voltage input at signal generator, cells can not be retained in ultrasonic filter,
cells just flow through the ultrasonic filter and were briefly exposed to the ultrasonic field.
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Figure 7.8 Cell growth comparison between cells cultured in 10% serum and 15% serum in an active
ultrasonic field, Vsg=300 mVpp, Frequency is about 1.13 MHz.

When voltage at signal generator was increased from 40 mVpp to 300 mVpp to able to
retain cells in the ultrasonic filter, though the serum concentration was increased from
10% to 15%, antibody production was still sharply reduced over 70% compared to the
control experiment. Similarly, if the antibody that existed in the inoculum is taken into
account, less than 10% of antibody was produced compared to the control test. This
should be caused by higher stress from the ultrasonic field and longer exposure time for
the cells grown in 15% serum free medium.

7.3.2.3 Effect of oxygen and residence time
The following experiment was done to rule out oxygen limitation as a cause of cell death
when almost all the cells were retained in the ultrasonic filter. A 140 mL spinner flask
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was used to couple with a 13 mL ultrasonic filter for the test. Oxygen for supporting the
retained cells in the ultrasonic filter is brought by the continuous influent culture medium
pumped from the spinner flask, in which the DO is 75%. 24 hours after inoculation, the
ultrasonic filter was powered on and circulation was started. Every 24 hours the
transducer was powered off, the retained cells were flushed back to spinner flask for
sampling to check the cell concentration and viability.

Signal generator voltages used in this set of experiments were 150 mVpp and 200 mVpp.
The results shown in Figure 7.10 indicate that the cells in the system with the ultrasonic
filter coupled to the 140 spinner flask died even more quickly than those cultured in the
ultrasonic filter coupled to the 1 L bioreactor when the voltage input in signal generator
was 300 mVpp, which is higher than the both tests shown in Figure 7.10. As shown in
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Figure 7.9 Antibody production at the end of cultures
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Cells grown with 15% serum
medium in 1 L bioreactor
with exposure to ultrasound
(Vsg=300mVpp, Fre=1.13

Figure 7.7, cell concentration increased indeed at 48 hours for the test with 300 mVpp
voltage input at signal. With same serum concentration, supposedly, cells should grown
better in the tests shown in Figure 4.10 with lower power level. .In the contrast, cell
concentration dropped at 48 hours for both tests in Figure 7.10.
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Figure 7.10. Long-term exposure to ultrasonic field for cells cultured in 10% serum medium (the ultrasonic
filter is combined with 140 mL spinner flask as shown in Figure 6.3).

The oxygen concentration in the spinner flask is 75% (measured with an oxygen probe)
when viable cell concentration is 5 x 105 cells/mL and the oxygen concentration in the
cell suspension that leaves the ultrasonic filter is estimated to be about 60% (See
Appendix B for calculation procedure). At this level cell growth and metabolism are not
limited by oxygen supply at all so oxygen limitation is not a cause for the fast cell death.

The volume of cell suspension in the spinner flask is smaller than that in the 1 L
traditional bioreactor, so the residence time of cells in this system was much longer than
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that in the 1 L bioreactor system. As shown in Appendix C, the exposure time to
ultrasonic field in the bioreactor system is about 5 hours (in 24 hours) while in the
spinner flask the exposure time is 21.7 hours (in 24 hours) when the Vsg and flow rate
are same. Therefore the negative effects largely relate to the exposure time of cells to the
ultrasonic field. Cell rupture was visually observed under the microscope after 24 hours
exposure. The sound field appears to be the cause of decrease in cell viability. This result
is in agreement with the results shown in Figure 7.3, in which Vsg is also 150 mVpp, for
cells cultured in 10% serum culture medium, about 90% cells were killed in 16 hours.

It was reported that the damage to yeast cells which are exposed to standing ultrasonic
waves is directly correlated to the exposure duration, especially when the cells are in the
displacement of pressure nodal planes.
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Both intracellular material leakage and

prolonged cell growth lag time were observed after the yeast cells exposing to ultrasonic
standing waves for one hour. Plant cell viability can be markedly influenced by exposing
to ultrasonic standing waves. In a period of 40 min exposing to standing ultrasonic filed
which able to retain the cells, the viability of plant cells dropped 80%.
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Cavitation

effect is unlikely the cause of death since the energy intensities used in that study was
relatively low. The damage mechanism is still not clear but mechanical stress induced by
acoustic pressure is very likely a major reason.
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CHAPTER VIII
AN ULTRASONIC FILTER FOR PARTICLE RETENTION USING
STANDING ULTRASONIC WAVES AT AN OBLIQUE ANGLE
WITH FLUID FLOW DIRECTION

8.1 Introduction
Ultrasonic filters currently are being used in long term mammalian cell perfusion
systems.16, 17, 20, 108 To retain the cells in the filter, the acoustic force must dominate the
hydraulic drag force of the fluid carrying the cells. The hindrance of hydraulic drag force
will prolong the residence time of collected cells in the ultrasonic filter, which is an
unfavorable environment for cell growth since there is no control of pH and DO. In order
to shorten the residence time, high recirculation flow rate was applied to facilitate the
removal of collected cells but in this way the average residence time of cell suspension
time is increased unavoidably.
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A novel ultrasonic filter is presented in this chapter. It was developed for separating
particles, like animal cells from an aqueous suspension. As with the inclined gravity
settler, it is expected to be used as a cell retention device for long-term perfusion cultures.
Unlike currently available ultrasonic filters, in which the particles concentrated by
standing ultrasonic waves leave the ultrasonic chamber in the opposite direction of the
carrying fluid,16, 20, 21, 106-108, 110, 118 the collected particles in this device move in the same
direction as the carrying fluid. In this way the hydraulic drag force facilitates rather than
hinder cell removal. Therefore the cell residence time in the ultrasonic filter is reduced,
which is preferred for cell growth and productivity.

8.2 Materials and Methods

8.2.1 Three Chamber Ultrasonic Filter with Oblique Middle Chamber

As shown in Figure 8.1 the ultrasonic filter is composed of three chambers. The middle
chamber is the functioning part of the device, with walls that are at oblique angles with
the transducers. There are two outlet ports at one end of the middle chamber; one is for
concentrated particles and the other is for clarified fluid. Water is pumped through the
two side chambers to prevent heat accumulation generated by the acoustic transducers.

The body of the chamber is made of 2 mm thick transparent polycarbonate sheet and 0.13
mm transparent polycarbonate film is used to separate the cooling chambers and the
middle chamber. The transducer carriers are made of 2 mm thick borosilicate glass. The
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inner dimension of the ultrasonic filter is 150 x 43 x 18 mm (height x width x thickness).
The longest width of the cooling chamber is 23 mm and

Cooling Water

Particle
Cooling Water
Suspension

Transducer

Transducer

Port I

Port II

Cooling Water

Cooling Water

Figure 8.1 Schematic of ultrasonic filter with oblique middle chamber

the narrowest width is 5mm. the width of the middle chamber in horizontal direction is 15
mm. This means the angle of the inclination of the middle chamber for the tested
ultrasonic filter is 6.8 o. Four pieces (two on each side) of 55 x 18 x 1 mm piezoelectric
lead zirconate titanate transducers (APC 880, American Piezo Ceramics, Inc.,
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Mackeyville, PA) with fundamental frequency around 2.1 MHz are used for the
excitation to maintain resonance in the acoustic filter, which are glued on the glass carrier.
The top edge of the ultrasonic transducer is 10 mm to the top end of the filter and the
lower edge is 30 mm to the low end of the ultrasonic filter.
G

Balanced Positions

FB

Fac

θ

FH

Nodal Planes

B

A

Figure 8.2 Force analyses of a particle in the filter, where G is gravity force, FB is buoyancy force, Fac is
the primary acoustic force, FH is hydrodynamic drag force

Primary acoustic force is calculated using the following equation.103, 104

Fac = 4πR 3κE ac sin( 2κx ) F

8.1

where κ is the wave number across the acoustic filter, Eac is energy density within the
suspension, x is the distance of the cell from the nearest pressure nodal plane, R is the
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particle radius, and F is the acoustic contrast factor. This factor is characteristic of the
suspension and is given by:
1 5ρ − 2 ρ f γ p
F= ( p
− )
3 ρ f + 2ρ p γ f

8.2

Where ρP is the density of the particle, ρf is the density of carrying fluid, γf is the
compressibility of carrying fluid,

γp is the compressibility of particle. The primary

acoustic force moves the particles to the pressure nodal planes or antinodal planes
determined by the particle and carrying fluid physical property in the ultrasonic standing
wave field.

Hydraulic drag force is calculated using the following equation:
FH = 6πµ (υ f − υ p ) R

8.3

where µ is the fluid viscosity, vf is the practical velocity, vp is the particle velocity, and R
is the radius of the spherical particle. 114

Let’s first consider particles that are homogeneous and have higher compressibility than
the carrying fluid, then the primary acoustic force moves the particles to the nearest
pressure nodal planes. As shown in Equation 8-1, the primary acoustic force is zero when
the particle is within a nodal plane and it increase to the maximum at the middle point
between two adjacent nodal planes. The hydraulic force has the tendency to push the
particles away from a nodal plane, causing primary acoustic force increase along with the
distance from the nodal plane. The forces in horizontal direction on the particle reaches a
balance When:
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FAc + FD sin θ = 0

8.4

Thus particles will collect in a plane a distance x away from the nodal plane as shown in
Figure 8.2 B. For particles with density greater than the carrying fluid, the gravity force is
larger than the buoyancy force. Therefore a particle in the middle chamber within the
setup as shown in Figure 8.1, will move down until reaching the lower surface of the
separator. Then collected particles on the separator surface will slide down along the
lower surface until they exit via port I. Here the hydraulic drag force parallel to the
separator surface will facilitate the particle removal since it has the same direction as the
particle movement as well as the gravity force. And relatively clarified fluid will leave
the middle chamber via Port II.
If the magnitude of horizontal direction of the hydraulic drag force is higher than the
largest primary acoustic force can occur at a given power input, then the particles just
will be carried out with the carrying fluid via Port II and no separation induced by the
acoustic force will happen. So there is a flow rate limit below which the separation occurs.

As shown in Equation 8-1 and 8-3, the primary acoustic force is proportional to the cube
of the particle radius and hydraulic force is proportional to the first power of the particle
radius. Therefore the primary force decrease more than the hydraulic force along with the
reduction of particles radius. This relative sensitivity to radius is the basis of separating
particle suspension with different diameter particles. The separation of a population of
particles by size was investigated using this device.
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8.2.2 Polystyrene Particles

Monodisperse standard polystyrene particles (Sigma, St. Louis, MO) with diameter 8, 10,
and 15 um diameter and 1.05 g/cm3 density were used to test the device. Particles with 8
um and 15 um diameter are translucent with no color stain. The particles with 10 um
diameter are made of polystyrene with blue color. This arrangement makes it easy to
distinguish the particles with 8 um and 10 um diameter when counting particle under
microscope. The particles were suspended in DI water supplemented with 0.1% Triton X100 (Sigma, St. Louis, MO), which helps prevent the particles from aggregating. The
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8.3 Cell or particle retention test setup

concentration of each type of particle in the mixture is from 1 to 2 million particles per
milliliter, which is similar to the cell concentration used in this study.
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8.2.3 Cell line and Medium

HB-159 Hybridoma cells (ATCC) are used for the cell retention tests conducted within
the ultrasonic filter. A serum free medium, BD Cell Mab Medium Serum Free, (BD
Biosciences - Advanced Bioprocessing) supplemented with 0.1% Pluronic F68 (Sigma,
St. Louis, MO) is used for cell culture. Cells were cultured in T-flasks first, then
transferred to a 2-L B.Braun stirred bioreactor and the working volume was 1.5 L.

8.2.4 Experimental Setups

As shown in 8.3, particle or cell suspension is pumped into the ultrasonic filter via the top
inlet, the concentrated stream leaving the port I will be returned back to bioreactor and
sample will be taken from the stream leaving port II after at least 4 residence times (of
fluid) in the filter. The flow direction of liquid in the filter is downward. For both particle
and cell retention tests, the flow rates via port I and port II are equal.

8.2.5 Analysis Methods

Cell density and viability were determined using hemocytometer count and trypan blue
exclusion method. Samples from the steam leaving the outlet ports were gathered during
quasi-steady period, at least after four residence times. The number of polystyrene
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particles in the effluent is determined using microscope with hemocytometer. The particle
identity is determined by both color and size.
The cell or particle retention rate, R, is defined as:

R=

XR − XO
× 100 %
XR

8.5

where XR is the cell or particle concentration in the bioreactor; XO is the cell or
paritcle concentration in the relatively clarified stream that exits port II from the
filter.

8.3 Results and Discussion

8.3.1 Polystyrene particle separation
Polystyrene particle suspension with three diameters was tested at first to confirm that the
device is not only able to separate particles from the carrying fluid but also has the
potential to separate the particles from each other based on size difference.

As shown in 8.4, near the top inlet area the cloud of particles in the suspension evenly
filled the middle chamber. Then the “cloud of particle” became thinner towards the
middle region of the filter. And when the clusters becomes large enough they were
observed to drop down to the lower surface of the middle chamber and slide down to the
port I.
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8.4 Photo of oblique acoustic separator operation of particles with three sizes

In the following studies, the performance of the ultrasonic filter with oblique middle
chamber was quantitatively evaluated. As shown in 8.5 for all three particles, the
retention rate goes down as flow rate increases. When the flow rate increase, the
hydraulic drag force increases as well, which results in small particle clusters
accumulated in the vertical plane. The particle retention capacity decreases accordingly.
The particle retention efficiency increases with particle diameter, as expected, although
the average difference is only about 5% between the 15 um and 8um diameter particles.
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8.5 Particle retention vs. perfusion rate. Voltage input at the signal generator is 900mVpp and average
power input at the transducer is 1 W. Particle suspension is a mixture of particles consists of 8um, 10um
and 15um polystyrene particles.

Apparently the particles cannot be separated thoroughly but at least the particles with
certain size range can be enriched by pumping particle suspension with mixed diameters
repeatedly through the ultrasonic filter.

Over 90% retention was achieved,, at the given power input level up to 23L/day, with 10
and 15 um particles. These two diameters are close to the mammalian cell size with
density similar to mammalian cells, so we speculate that mammalian cells also can be
efficiently retained, with selective retention of viable over nonviable cells.
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8.3.2 Cell Retention Test

As shown in 8.6 viable cell retention was always higher than that of nonviable cells. If we
consider the middle chamber as an inclined gravity settler, this device has a cell retention
capacity that is about 22 times that of an inclined gravity settler with the same surface
area but without the ultrasonic enhancement (see Figure 5.3 in Chapter V).
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8.6 Cell retention vs. flow rate with signal generator voltage of 2.8Vrms and average power input on the
transducers of 13.9 W. The cell line used is the HB-159 hybridoma.

The difference of retention between viable cells and nonviable is less than 5% at most of
sampling points and the average is less 10%, while for the inclined gravity settler the
difference is above 20%. This means the selectivity of the ultrasonic filter is significantly
smaller than the gravity settler. Smaller particle in the filter has more chance to be
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washed out but it is the situation before they form a large multiple cell cluster with other
particles. The closer the small particle is to the lower surface the less chance it can be
washed out since it need travel across more layer of nodal planes than the particles in
further locations. In the contrast, in gravity settler the separation is mostly to deal with
single cells. There is little chance the smaller nonviable cell can form a cluster with other
cells during the settling process. For the similar reason, pervious developed upward-flow
ultrasonic filters have smaller selectivity than inclined gravity settler, in which the small
particles need travel upwardly through the filter working chamber across the ultrasonic
standing waves. The longer the path is the less chance the small particles can be washed
out. Therefore, if the culture is very sensitive of viability, then the inclined gravity settler
should be selected as cell retention device even its capacity is smaller than the ultrasonic
filter based on unit settling surface area.
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CHAPTER IX
DISCUSSION

In this study, modifications and characterizations of three cell retention approaches were
presented: inclined gravity settler, acoustic filter filled with porous mesh, and acoustic
filter with an oblique middle chamber.

9.1 Gravity Settler
The major advantages of using an inclined gravity settler for cell retention are: its easy of
use; and economical to manufacture. The major advance of the downward flow inclined
gravity settler presented here, is that for a unit working surface area, our downward flow
inclined gravity settler has a capacity that is about three-fold greater than that of the
commercially available inclined gravity settlers (e.g., from Biotechnology Solutions, Inc.).
One factor affecting the performance of this device is the cell settling velocity. The
settling velocity differs significantly among cell lines and it changes substantially when
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cell viability drops for same cell line. The cell settling velocity measurement should thus
be performed routinely for each cell line both before and during the perfusion culture
when a gravity settler is used for cell retention. In this way a gravity settler with enough
capacity can be selected a priori to maximize viable cell retention efficiency.
Furthermore, the time-dependency of the cell size and thus the settling velocity indicates
that a gravity settler with real-time adjustable capacity is preferred for optimal cell
retention. The settling velocity measurement device developed and presented here is
unique and is a simple and inexpensive method for measuring the velocity of the viable
and nonviable cells.

9.2 Acoustic Filter Filled with Porous Mesh
An acoustic filter with a porous mesh designed for non-cellular particle filtration was
characterized for use in mammalian cell retention.

This approach presents an

improvement of the commercial acoustic filters by including a porous mesh in the
acoustically-active chamber. It was found that the power input could be reduced up to
39% for the same cell retention capacity. This represents an improvement in acoustic
filtration for cell retention, especially when cell growth and productivity are sensitive to
power input levels. For long-term, large-scale applications, this power reduction can
result in significant cost-savings.
As with the commercial acoustic filters, this acoustic filter filled with porous mesh still
needs on-and-off cycles.17, 108, 118 This on-and-off cycle not only requires the complexity
of specific control system, but it also lowers the capacity of the device, since when the
filter is turned off, it is not retaining cells but permiting the retained cells to return to the
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bioreactor. Thus the filter has a nonworking period within each cycle. In order to solve
this issue we developed a novel acoustic filter which can be operated continuously.

9.3 Acoustic Filter with an Oblique Middle Chamber

Cells in the carrying fluid can be effectively separated under the combined effects of
acoustic, gravity and hydraulic drag forces using this novel ultrasonic filter with an
oblique middle chamber. This design has an advantage over the previously developed
ultrasonic filters for particle recovery or concentration because the moving direction of
collected particles or aqueous droplets is same as the carrying fluid. Experiments proved
that the new design is able to be operated continuously, while the on-and-off cycles have
to be arranged for the previously developed ultrasonic filters, which simplified the
operation and lowered hardware requirements.

9.4 Selection of Cell Retention Approach

With further optimization of this design, it is believed that it can achieve separation
efficiencies similar to commercial units, with simpler hardware/software design, lower
power input per flow capacity, and smaller transducer area per flow capacity.

Both gravity settlers and acoustic filters are being successfully used in industrial
applications. There is not doubt about their stability for long-term cell retention
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applications. The biggest difference between acoustic filters and inclined gravity settler is
the construction cost. For 200 L/day capacity the price of a commercial acoustic filter
system is more than 10-fold that of an inclined gravity settler. If the cell retention device
will be used many times, the one-time investment of an acoustic filter system might be
acceptable. However, for single-use disposable systems, of which the bioreactor market is
increasing dramatically, only an inclined gravity settler can make economic sense. .

The working volume of the acoustic filter is much smaller than an inclined gravity settler.
Therefore if a cell line is very sensitive to growth environment, like pH and DO, then an
acoustic filter is preferred for the cell retention task. Currently the largest available
acoustic filter system is 200 L/day (Applikon Biotechnology), while the largest gravity
settler available is 500 L/day (Biotechnology Solutions). The scalability of gravity settler
is better than the acoustic filter. This is because the output of the acoustic transducer is
limited and the cooling system requirement for removing the heat generated by acoustic
transducers. The power consumption of acoustic filter system is significantly greater
than that used in the pumps of the inclined gravity settler, but given the high cost of
biotechnology products, this factor is not significant for the selection of cell retention
devices for perfusion culture systems. On the other hand, for the production of biofuel
from algae in very large-scale systems, the higher energy cost of the acoustic filter
precludes the use of this system.

All the devices tested in this study were constructed in the lab manually. It is expected
that better performance of the devices can be achieved by professional fabrication.
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CHAPTER X
CONCLUSION AND RECOMMENDATIONS

10.1 Gravity Settlers

10.1.1 Bench-Top Scale Gravity Settlers

The results of the culture tests show that this gravity settler is a reliable cell retention
device for long-term (at least two months) high-density perfusion culture. The antibody
productivities were stable during the first phase run of 0.8 day-1 perfusion rate for both
cell lines tested. This implies that perfusion culture using this device for cell retention can
be conducted long-term with no sacrifice of productivity.
Our study shows that with a 1 L perfusion bioreactor, it is feasible to provide enough
cells to seed a bioreactor with working volume of 250 liter. The expansion rate of 250fold is tens times that of conventional processes. A total of 6.4 days was required to
achieve this inoculum, counting from when the perfusion rate was gradually increased
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until it was doubled. This indicates that less than 1/3 of the time for inoculum preparation
was needed, compared to the conventional 3 to 4 week schedule.

10.1.2 Settling Velocity Measurement Column

The settling column described in Chapter IV provides an inexpensive, rapid, and accurate
method for determining cell settling velocities and that can distinguish the settling
velocities of viable and nonviable cells. The method was validated using polystyrene
particles with known physical properties, and resulted in less than 4% error compared to
the theoretical value obtained using Stokes’ law.

10.1.3 Gravity Settler Scale-up

With short-term cell retention tests, it was shown that this downward flow inclined
gravity settler is scalable to industry level for mammalian cell perfusion cultures. When
scaling up, there is a maximum feasible settler length, since an increase in settler length
increases the cell retention time, which is not favored for cell growth and productivity.
The efficiency of cell retention decreases with increase of settler length. With increased
inlets to help the flow distribution the width of the settler can be increased with no
foreseen limitation.
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The primary algae dewatering tests showed that the inclined gravity settler can effectively
assist in water removal task and it can be operated continuously for three weeks. From
our preliminary results, algae culture can be concentrated at least 4-fold.

10.2 Acoustic Filter
10.2.1 Effect of Porous Mesh and Transducer Attachment Method
The collection or retention of fine particles, like hybridoma cells, from a flowing
suspension can be enhanced using an acoustically driven porous polymer mesh having
pore size two orders of magnitude larger than the particles. The power input with porous
mesh acoustic filter can be significantly reduced compared to the control experiments,
36% reduction at 0.50 mm/min, 39% reduction at 0.75 mm/min and 14% reduction at 1
mm/min fluid velocity. Alternatively, with the same power input, the acoustic filter with
mesh allows the retention of the same amount of cells in less time. Lower exposure time
to ultrasonic field or lower power input is helpful for both the long-term cell viability and
productivity.
The flexible attachment of the acoustic transducer to the filter frame can also
significantly reduce the power input needed for maintaining the same level of cell
retention capacity, compared to that achieved with a rigidly affixed transducer. The
significance of using the porous mesh is not only about energy saving but also the
increase of operating range.
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10.2.3 Impact of Ultrasonic Field on Cell Growth and Productivity

Long-term exposure to ultrasonic standing waves negatively impact cell growth and
antibody productivity at the levels of power input that are needed to retain cells and even
at power levels significantly less. Damage to cells was found to be proportional to power
input and exposure time. Serum had a small mitigating effect on the damage. Therefore it
is not feasible to use an ultrasonic filter as a means to culture cells like a regular cell
culture vessel.

10.2.4 Acoustic Filter with An Oblique Middle Chamber
The design of this device combines features of both the gravity settler and the ultrasonic
systems to efficiently recover particles or cells. With assistance of the ultrasonic standing
waves, particles in the suspension are gathered before they reach the settling surface. It
virtually increases the size of the aggregate to be settled resulting in much shorter
settling time. For the same unit surface area, the cell retention capacity of the acoustic
filter is 22-fold that of the inclined gravity settler.

10.3 Recommendations
Small to medium scale of tests were conducted with gravity settler for both applications
with mammalian cells and algae culture. Further scale-up research should be conducted
based. The first scale-up approach, in actual systems coupled with bioreactors, will
involve putting multiple channels together as shown in Figure 10.1. This settler should
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have minimum total capacity of 50 L/day. The multiple channel design not only increases
total handling capacity but also gives flexibility of operation especially for cell retention
purpose. As shown in Figure 10.1, each channel is attached with a valve, which means
the number of channels that will be used in the task can be controlled. By adding
channels one by one during the task, the perfusion rate can be increased gradually
without sacrificing cell retention efficiency. This design will be able to handle capacity
from 50-200 L/day.
Air vent

Outlets

Inlets

Figure 10.1 Multiple channel gravity settler with minimum 50 L/day capacity

Next step, scale-up can be accomplished by stacking multiple plates of settlers to further
increase the handling capacity as shown in Figure 10.2. The capacity of this type of
settler is over 200 L/day. Future work on this settler is to make sure the flow distributes
equally on each level. Flow distribution throttle might be needed for the even distribution
of fluid in each layer.

For the ultrasonic filter with oblique middle chamber, the future emphasis lies in three
aspects, optimization, actual perfusion culture tests, and scale-up. The optimization
includes material design and material optimization. The inclination angle of the middle
chamber was chosen randomly for preliminary tests. There is much room for further
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Figure 10.2 1000 L/day capacity multi-layer inclined gravity settler with shared plates (side view)

optimization by mathematical modeling and experimentation. The aim is to maximize the
particle handling capacity for a given working volume, which is the middle chamber
volume. Another optimization is the material selection. Polycarbonate film was used to
insulate the middle chamber from the cooling chambers. During tests, it was observed
that the film tended to deform when there is imbalanced pressure on its two sides, which
will cause extra resistance for cells to leave the middle chamber. Glass or stainless steel
may have better performance.
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After design optimization, the filter should be tested with actual perfusion culture to
evaluate its reliability during long term use and to determine if there is negative impact
on cell growth and productivity. There are two approaches to scale-up of ultrasonic filter.
The first one is simply increase the working volume by increasing the width of the filter.
All the recommended work is in conceptual phase and actual size need to be determined
by further tests.
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APPENDIX A ELISA PROCEDURE
Elisa kit (Alpha Diagnostic International, San Antonio, TX) Anti-Mouse IgG1 coated
strip plate (96 wells) was used for the IgG1 antibody concentration measurement. The
plate was pre-coated with Coated with purified anti-Mouse IgG1 antibodies.

BLOCKING

1. Dispense 250 ul blocking buffer per well and Incubate plates for 2-6 h at room
temperature or overnight at 4oC with gentle mixing.
2. Aspirate blocking buffer solution and tap over paper towels to remove all solution.
The plates can be used directly for the assay or kept at 4oC in sealed bag for future
use.

ANTIBODY ASSAY

1. Dilute samples, standard and control in Antibody/Conjugate Diluent (Serial
dilution's of 1:10, 1:100, up to 1:100000K for standard IgG1 antibody). Dispense
100 ml to the pre-coated wells
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2. Cover the plates with adhesive films. Incubate at room temperature for 30 min
with gentle orbital shaking.
3. Aspirate solution and wash plates 5X with wash buffer (200-300 ul wash buffer
should be used for each washing).
4. Dilute Anti-Rabbit IgG-HRP Conjugate (1:5000-1:20000) in Antibody Conjugate
diluent. Dispense 100 ul of conjugate per well.
5. Cover the plates with adhesive films. Incubate at room temperature for 30 min
with gentle orbital shaking.
6. Aspirate plates and wash plates 5X with wash buffer. Tap over paper towels to
remove all solution.
7. Dispense 100 ul/per well of ready-to-use tetramethylbenzidine (TMB) substrate
solution.
8. Cover the plates with adhesive films. Incubate at room temperature for up to 15
min with gentle orbital shaking. A blue color will develop in positive wells.
9. Dispense 100 ul diluted stop solution per well. The blue color will turn into
yellow.
10. Read absorbance at 450 nm.
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APPENDIX B OXYGEN CONSUMPTION ESTIMATION

Concentration of oxygen in culture medium at 37 degree Celsius saturated with air is 0.21
mmol/L. Oxygen consumption rate (q) of hybridoma is 0.22*10-12 mol/cell/hour.126

We assume the all cells in the spinner flask were retained in the ultrasonic filter.

Then the mass balance of oxygen

X • q • V = F (Ci − Co )
where t is the experiment duration, X is cell concentration in spinner flask before the cell
retention process started, V is working volume of the spinner flask, F is culture medium
flow rate through the ultrasonic filter, oxygen concentration in influent stream at the inlet
of the ultrasonic filter is Ci and in the effluent stream at the outlet is Co. Concentration of
oxygen in spinner flask is Ci =0.21*0.75=0.157mmol/L when DO is 75%
So
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Co = Ci −

X • q •V
F

X is equal to 5x105 cells/mL and V is equal to 140 mL.

Co=0.126mmol/L which is 60% in terms of DO
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APPENDIX C CELL EXPOSURE TIME ESTIMATE IN THE
ULTRASONIC FILTER

At the same level of voltage input (150 mVpp) of the signal generator, the residence time
in the spinner flask system and the 1 L bioreactor system are estimated as the following:

The working volume for the spinner flask is 140 mL and the traditional bioreactor is 1100
mL. The acoustic chamber volume is 13 mL. The cell suspension flow rate through the
acoustic chamber is 30mL/min.

Hypothesis I: No cells are retained in the ultrasonic filter.

Then the average exposure time:

For cells in the bioreactor system is 24*13/1100=0.27hours

Hypothesis II: The retention is 100% in the spinner flask and the cells were retained with
even speed.
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In the 1L bioreactor culture vessel, the cell concentration was 5.4 x 105 cells/mL. After
24 hours, the retention is 40%. We assume cell accumulation in the filter does not
influence the retaining efficiency.

The total average exposure time for the cells grown in 1 L bioreactor system should be:

24*40%/2+0.27-0.27*40%/2= 5.02 hours.

Then, the retaining rate at 150 mVpp input of signal generator is 540000
cell/mL*1100mL *40%/24 hour=9.9*106 cells/hour.

Cell concentration in the spinner flask is 4.6*105 cells/mL. The retention will be finished
in 460000*140/9900000=6.5 hours.

Suppose that no cells were retained in the first 6.5 hours, and then the average exposure
time is 6.5*13/140=0.6 hours.

The total average exposure time in the spinner flask system should be:

(24-6.5)+6.5/2+0.6/2=21.7hours.
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The exposure time evaluation is performed with two hypotheses, so it is not absolutely
accurate but it can give clues for showing the difference in exposure time between the
two systems.
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